000157873212-31Q12025falseP2YP1YP4Yone yearone282xbrli:sharesiso4217:USDiso4217:USDxbrli:sharesmmi:officexbrli:puremmi:securitymmi:reportingUnitmmi:installmentmmi:segment00015787322025-01-012025-03-3100015787322025-05-0200015787322025-03-3100015787322024-12-310001578732mmi:RealEstateBrokerageCommissionsMember2025-01-012025-03-310001578732mmi:RealEstateBrokerageCommissionsMember2024-01-012024-03-310001578732mmi:FinancingFeesMember2025-01-012025-03-310001578732mmi:FinancingFeesMember2024-01-012024-03-310001578732mmi:OtherRevenuesMember2025-01-012025-03-310001578732mmi:OtherRevenuesMember2024-01-012024-03-3100015787322024-01-012024-03-310001578732us-gaap:PreferredStockMember2024-12-310001578732us-gaap:CommonStockMember2024-12-310001578732us-gaap:AdditionalPaidInCapitalMember2024-12-310001578732us-gaap:RetainedEarningsMember2024-12-310001578732us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-12-310001578732us-gaap:RetainedEarningsMember2025-01-012025-03-310001578732us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-01-012025-03-310001578732us-gaap:AdditionalPaidInCapitalMember2025-01-012025-03-310001578732us-gaap:CommonStockMember2025-01-012025-03-310001578732us-gaap:PreferredStockMember2025-03-310001578732us-gaap:CommonStockMember2025-03-310001578732us-gaap:AdditionalPaidInCapitalMember2025-03-310001578732us-gaap:RetainedEarningsMember2025-03-310001578732us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-03-310001578732us-gaap:PreferredStockMember2023-12-310001578732us-gaap:CommonStockMember2023-12-310001578732us-gaap:AdditionalPaidInCapitalMember2023-12-310001578732us-gaap:RetainedEarningsMember2023-12-310001578732us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-3100015787322023-12-310001578732us-gaap:RetainedEarningsMember2024-01-012024-03-310001578732us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-01-012024-03-310001578732us-gaap:AdditionalPaidInCapitalMember2024-01-012024-03-310001578732us-gaap:CommonStockMember2024-01-012024-03-310001578732us-gaap:PreferredStockMember2024-03-310001578732us-gaap:CommonStockMember2024-03-310001578732us-gaap:AdditionalPaidInCapitalMember2024-03-310001578732us-gaap:RetainedEarningsMember2024-03-310001578732us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-03-3100015787322024-03-310001578732mmi:CustomerMembercountry:CAus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2025-01-012025-03-310001578732mmi:CustomerMembercountry:CAus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-01-012024-03-310001578732us-gaap:PerformanceSharesMember2025-01-012025-03-310001578732mmi:EmployeeStockPurchasePlanMember2025-01-012025-03-310001578732us-gaap:ComputerEquipmentMember2025-03-310001578732us-gaap:ComputerEquipmentMember2024-12-310001578732us-gaap:FurnitureAndFixturesMember2025-03-310001578732us-gaap:FurnitureAndFixturesMember2024-12-310001578732us-gaap:ShortTermInvestmentsMemberus-gaap:USTreasurySecuritiesMember2025-03-310001578732us-gaap:ShortTermInvestmentsMemberus-gaap:CorporateDebtSecuritiesMember2025-03-310001578732us-gaap:ShortTermInvestmentsMember2025-03-310001578732mmi:LongTermInvestmentsMemberus-gaap:USTreasurySecuritiesMember2025-03-310001578732mmi:LongTermInvestmentsMemberus-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember2025-03-310001578732mmi:LongTermInvestmentsMemberus-gaap:CorporateDebtSecuritiesMember2025-03-310001578732mmi:LongTermInvestmentsMemberus-gaap:AssetBackedSecuritiesMember2025-03-310001578732mmi:LongTermInvestmentsMember2025-03-310001578732us-gaap:ShortTermInvestmentsMemberus-gaap:USTreasurySecuritiesMember2024-12-310001578732us-gaap:ShortTermInvestmentsMemberus-gaap:CorporateDebtSecuritiesMember2024-12-310001578732us-gaap:ShortTermInvestmentsMember2024-12-310001578732mmi:LongTermInvestmentsMemberus-gaap:USTreasurySecuritiesMember2024-12-310001578732mmi:LongTermInvestmentsMemberus-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember2024-12-310001578732mmi:LongTermInvestmentsMemberus-gaap:CorporateDebtSecuritiesMember2024-12-310001578732mmi:LongTermInvestmentsMemberus-gaap:AssetBackedSecuritiesMember2024-12-310001578732mmi:LongTermInvestmentsMember2024-12-310001578732us-gaap:USTreasurySecuritiesMember2025-03-310001578732us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember2025-03-310001578732us-gaap:CorporateDebtSecuritiesMember2025-03-310001578732us-gaap:AssetBackedSecuritiesMember2025-03-310001578732us-gaap:USTreasurySecuritiesMember2024-12-310001578732us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember2024-12-310001578732us-gaap:CorporateDebtSecuritiesMember2024-12-310001578732us-gaap:AssetBackedSecuritiesMember2024-12-3100015787322024-01-012024-12-3100015787322024-01-012024-06-300001578732mmi:SecurityDepositMember2025-03-310001578732mmi:SecurityDepositMember2024-12-310001578732mmi:EmployeeNotesReceivableMember2025-03-310001578732mmi:EmployeeNotesReceivableMember2024-12-310001578732mmi:DebtSecuritiesHeldToMaturityMember2024-12-310001578732mmi:DebtSecuritiesHeldToMaturityMember2025-03-310001578732mmi:LoanPerformanceFeeReceivableMember2025-03-310001578732mmi:LoanPerformanceFeeReceivableMember2024-12-310001578732mmi:InvestmentsInConvertibleNotesMember2025-03-310001578732mmi:InvestmentsInConvertibleNotesMember2024-12-310001578732mmi:OtherMember2025-03-310001578732mmi:OtherMember2024-12-310001578732us-gaap:PreferredStockMember2024-09-012024-09-010001578732us-gaap:PreferredStockMember2024-08-262024-08-260001578732us-gaap:PreferredStockMember2025-01-012025-03-310001578732mmi:InvestmentsInConvertibleNotesMember2023-10-012023-12-310001578732srt:MinimumMembermmi:InvestmentsInConvertibleNotesMember2025-03-310001578732srt:MaximumMembermmi:InvestmentsInConvertibleNotesMember2025-03-310001578732mmi:MeasurementInputWeightedAverageTermMembermmi:InvestmentsInConvertibleNotesMember2025-03-310001578732us-gaap:StockAppreciationRightsSARSMember2013-03-310001578732us-gaap:StockAppreciationRightsSARSMember2025-03-310001578732us-gaap:StockAppreciationRightsSARSMember2014-01-012014-01-010001578732us-gaap:StockAppreciationRightsSARSMember2024-01-012024-01-010001578732us-gaap:StockAppreciationRightsSARSMember2023-01-012023-01-010001578732us-gaap:StockAppreciationRightsSARSMember2025-01-012025-03-310001578732us-gaap:StockAppreciationRightsSARSMember2024-01-012024-03-310001578732mmi:CommissionsPayableMember2025-01-012025-03-310001578732mmi:DeferredCompensationLiabilityMembersrt:MinimumMember2025-01-012025-03-310001578732mmi:DeferredCompensationLiabilityMembersrt:MaximumMember2025-01-012025-03-310001578732mmi:DeferredCompensationLiabilityMember2025-01-012025-03-310001578732mmi:DeferredCompensationLiabilityMember2024-01-012024-03-310001578732us-gaap:RelatedPartyMembermmi:MarcusAndMillichapCompanyMembermmi:TransitionServicesAgreementMember2025-01-012025-03-310001578732us-gaap:RelatedPartyMembermmi:MarcusAndMillichapCompanyMembermmi:TransitionServicesAgreementMember2024-01-012024-03-310001578732us-gaap:RelatedPartyMembermmi:MarcusAndMillichapCompanyMember2025-01-012025-03-310001578732us-gaap:RelatedPartyMembermmi:MarcusAndMillichapCompanyMembermmi:BrokerageAndFinancingServicesMember2025-01-012025-03-310001578732us-gaap:RelatedPartyMembermmi:MarcusAndMillichapCompanyMember2024-01-012024-03-310001578732us-gaap:RelatedPartyMembermmi:MarcusAndMillichapCompanyMembermmi:BrokerageAndFinancingServicesMember2024-01-012024-03-310001578732mmi:MarcusAndMillichapCompanyMember2025-01-012025-03-310001578732mmi:MarcusAndMillichapCompanyMember2024-01-012024-03-310001578732mmi:MarcusAndMillichapCompanyMember2025-03-310001578732mmi:MarcusAndMillichapCompanyMember2024-12-310001578732us-gaap:RelatedPartyMembermmi:MarcusAndMillichapCompanyMember2025-03-310001578732us-gaap:RelatedPartyMembermmi:MarcusAndMillichapCompanyMember2024-12-310001578732us-gaap:RelatedPartyMember2025-03-310001578732us-gaap:RelatedPartyMember2024-12-310001578732mmi:ChairmanAndFounderMember2025-01-012025-03-310001578732us-gaap:FairValueMeasurementsRecurringMembermmi:InvestmentsHeldInRabbiTrustMember2025-03-310001578732us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMembermmi:InvestmentsHeldInRabbiTrustMember2025-03-310001578732us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMembermmi:InvestmentsHeldInRabbiTrustMember2025-03-310001578732us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMembermmi:InvestmentsHeldInRabbiTrustMember2025-03-310001578732us-gaap:FairValueMeasurementsRecurringMembermmi:InvestmentsHeldInRabbiTrustMember2024-12-310001578732us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMembermmi:InvestmentsHeldInRabbiTrustMember2024-12-310001578732us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMembermmi:InvestmentsHeldInRabbiTrustMember2024-12-310001578732us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMembermmi:InvestmentsHeldInRabbiTrustMember2024-12-310001578732us-gaap:FairValueMeasurementsRecurringMember2025-03-310001578732us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2025-03-310001578732us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2025-03-310001578732us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2025-03-310001578732us-gaap:FairValueMeasurementsRecurringMember2024-12-310001578732us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2024-12-310001578732us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2024-12-310001578732us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2024-12-310001578732us-gaap:CommercialPaperMemberus-gaap:FairValueMeasurementsRecurringMember2025-03-310001578732us-gaap:CommercialPaperMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2025-03-310001578732us-gaap:CommercialPaperMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2025-03-310001578732us-gaap:CommercialPaperMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2025-03-310001578732us-gaap:CommercialPaperMemberus-gaap:FairValueMeasurementsRecurringMember2024-12-310001578732us-gaap:CommercialPaperMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2024-12-310001578732us-gaap:CommercialPaperMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2024-12-310001578732us-gaap:CommercialPaperMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2024-12-310001578732us-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMember2025-03-310001578732us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2025-03-310001578732us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2025-03-310001578732us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2025-03-310001578732us-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMember2024-12-310001578732us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2024-12-310001578732us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2024-12-310001578732us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2024-12-310001578732us-gaap:ShortTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USTreasurySecuritiesMember2025-03-310001578732us-gaap:FairValueInputsLevel1Memberus-gaap:ShortTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USTreasurySecuritiesMember2025-03-310001578732us-gaap:FairValueInputsLevel2Memberus-gaap:ShortTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USTreasurySecuritiesMember2025-03-310001578732us-gaap:FairValueInputsLevel3Memberus-gaap:ShortTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USTreasurySecuritiesMember2025-03-310001578732us-gaap:ShortTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USTreasurySecuritiesMember2024-12-310001578732us-gaap:FairValueInputsLevel1Memberus-gaap:ShortTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USTreasurySecuritiesMember2024-12-310001578732us-gaap:FairValueInputsLevel2Memberus-gaap:ShortTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USTreasurySecuritiesMember2024-12-310001578732us-gaap:FairValueInputsLevel3Memberus-gaap:ShortTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USTreasurySecuritiesMember2024-12-310001578732us-gaap:ShortTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateDebtSecuritiesMember2025-03-310001578732us-gaap:FairValueInputsLevel1Memberus-gaap:ShortTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateDebtSecuritiesMember2025-03-310001578732us-gaap:FairValueInputsLevel2Memberus-gaap:ShortTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateDebtSecuritiesMember2025-03-310001578732us-gaap:FairValueInputsLevel3Memberus-gaap:ShortTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateDebtSecuritiesMember2025-03-310001578732us-gaap:ShortTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateDebtSecuritiesMember2024-12-310001578732us-gaap:FairValueInputsLevel1Memberus-gaap:ShortTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateDebtSecuritiesMember2024-12-310001578732us-gaap:FairValueInputsLevel2Memberus-gaap:ShortTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateDebtSecuritiesMember2024-12-310001578732us-gaap:FairValueInputsLevel3Memberus-gaap:ShortTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateDebtSecuritiesMember2024-12-310001578732us-gaap:ShortTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMember2025-03-310001578732us-gaap:FairValueInputsLevel1Memberus-gaap:ShortTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMember2025-03-310001578732us-gaap:FairValueInputsLevel2Memberus-gaap:ShortTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMember2025-03-310001578732us-gaap:FairValueInputsLevel3Memberus-gaap:ShortTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMember2025-03-310001578732us-gaap:ShortTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMember2024-12-310001578732us-gaap:FairValueInputsLevel1Memberus-gaap:ShortTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMember2024-12-310001578732us-gaap:FairValueInputsLevel2Memberus-gaap:ShortTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMember2024-12-310001578732us-gaap:FairValueInputsLevel3Memberus-gaap:ShortTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMember2024-12-310001578732mmi:LongTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USTreasurySecuritiesMember2025-03-310001578732us-gaap:FairValueInputsLevel1Membermmi:LongTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USTreasurySecuritiesMember2025-03-310001578732us-gaap:FairValueInputsLevel2Membermmi:LongTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USTreasurySecuritiesMember2025-03-310001578732us-gaap:FairValueInputsLevel3Membermmi:LongTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USTreasurySecuritiesMember2025-03-310001578732mmi:LongTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USTreasurySecuritiesMember2024-12-310001578732us-gaap:FairValueInputsLevel1Membermmi:LongTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USTreasurySecuritiesMember2024-12-310001578732us-gaap:FairValueInputsLevel2Membermmi:LongTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USTreasurySecuritiesMember2024-12-310001578732us-gaap:FairValueInputsLevel3Membermmi:LongTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USTreasurySecuritiesMember2024-12-310001578732mmi:LongTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember2025-03-310001578732us-gaap:FairValueInputsLevel1Membermmi:LongTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember2025-03-310001578732us-gaap:FairValueInputsLevel2Membermmi:LongTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember2025-03-310001578732us-gaap:FairValueInputsLevel3Membermmi:LongTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember2025-03-310001578732mmi:LongTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember2024-12-310001578732us-gaap:FairValueInputsLevel1Membermmi:LongTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember2024-12-310001578732us-gaap:FairValueInputsLevel2Membermmi:LongTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember2024-12-310001578732us-gaap:FairValueInputsLevel3Membermmi:LongTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember2024-12-310001578732mmi:LongTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateDebtSecuritiesMember2025-03-310001578732us-gaap:FairValueInputsLevel1Membermmi:LongTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateDebtSecuritiesMember2025-03-310001578732us-gaap:FairValueInputsLevel2Membermmi:LongTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateDebtSecuritiesMember2025-03-310001578732us-gaap:FairValueInputsLevel3Membermmi:LongTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateDebtSecuritiesMember2025-03-310001578732mmi:LongTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateDebtSecuritiesMember2024-12-310001578732us-gaap:FairValueInputsLevel1Membermmi:LongTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateDebtSecuritiesMember2024-12-310001578732us-gaap:FairValueInputsLevel2Membermmi:LongTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateDebtSecuritiesMember2024-12-310001578732us-gaap:FairValueInputsLevel3Membermmi:LongTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateDebtSecuritiesMember2024-12-310001578732mmi:LongTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:AssetBackedSecuritiesMember2025-03-310001578732us-gaap:FairValueInputsLevel1Membermmi:LongTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:AssetBackedSecuritiesMember2025-03-310001578732us-gaap:FairValueInputsLevel2Membermmi:LongTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:AssetBackedSecuritiesMember2025-03-310001578732us-gaap:FairValueInputsLevel3Membermmi:LongTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:AssetBackedSecuritiesMember2025-03-310001578732mmi:LongTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:AssetBackedSecuritiesMember2024-12-310001578732us-gaap:FairValueInputsLevel1Membermmi:LongTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:AssetBackedSecuritiesMember2024-12-310001578732us-gaap:FairValueInputsLevel2Membermmi:LongTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:AssetBackedSecuritiesMember2024-12-310001578732us-gaap:FairValueInputsLevel3Membermmi:LongTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:AssetBackedSecuritiesMember2024-12-310001578732mmi:LongTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMember2025-03-310001578732us-gaap:FairValueInputsLevel1Membermmi:LongTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMember2025-03-310001578732us-gaap:FairValueInputsLevel2Membermmi:LongTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMember2025-03-310001578732us-gaap:FairValueInputsLevel3Membermmi:LongTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMember2025-03-310001578732mmi:LongTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMember2024-12-310001578732us-gaap:FairValueInputsLevel1Membermmi:LongTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMember2024-12-310001578732us-gaap:FairValueInputsLevel2Membermmi:LongTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMember2024-12-310001578732us-gaap:FairValueInputsLevel3Membermmi:LongTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMember2024-12-310001578732mmi:ContingentConsiderationMember2025-03-310001578732mmi:ContingentConsiderationMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2025-03-310001578732mmi:ContingentConsiderationMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2025-03-310001578732mmi:ContingentConsiderationMemberus-gaap:FairValueInputsLevel3Member2025-03-310001578732mmi:ContingentConsiderationMember2024-12-310001578732mmi:ContingentConsiderationMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2024-12-310001578732mmi:ContingentConsiderationMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2024-12-310001578732mmi:ContingentConsiderationMemberus-gaap:FairValueInputsLevel3Member2024-12-310001578732us-gaap:FairValueMeasurementsRecurringMembersrt:MinimumMember2025-01-012025-03-310001578732us-gaap:FairValueMeasurementsRecurringMembersrt:MaximumMember2025-01-012025-03-310001578732mmi:ContingentConsiderationMember2023-12-310001578732mmi:ContingentConsiderationMember2025-01-012025-03-310001578732mmi:ContingentConsiderationMember2024-01-012024-03-310001578732mmi:ContingentConsiderationMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:ValuationTechniqueDiscountedCashFlowMember2025-03-310001578732us-gaap:FairValueMeasurementsRecurringMembersrt:MinimumMembermmi:ContingentConsiderationMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputExpectedTermMemberus-gaap:ValuationTechniqueDiscountedCashFlowMember2025-03-310001578732us-gaap:FairValueMeasurementsRecurringMembersrt:MaximumMembermmi:ContingentConsiderationMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputExpectedTermMemberus-gaap:ValuationTechniqueDiscountedCashFlowMember2025-03-310001578732us-gaap:FairValueMeasurementsRecurringMembersrt:WeightedAverageMembermmi:ContingentConsiderationMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputExpectedTermMemberus-gaap:ValuationTechniqueDiscountedCashFlowMember2025-03-310001578732us-gaap:FairValueMeasurementsRecurringMembersrt:MinimumMembermmi:ContingentConsiderationMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputDiscountRateMemberus-gaap:ValuationTechniqueDiscountedCashFlowMember2025-03-310001578732us-gaap:FairValueMeasurementsRecurringMembersrt:MaximumMembermmi:ContingentConsiderationMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputDiscountRateMemberus-gaap:ValuationTechniqueDiscountedCashFlowMember2025-03-310001578732us-gaap:FairValueMeasurementsRecurringMembersrt:WeightedAverageMembermmi:ContingentConsiderationMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputDiscountRateMemberus-gaap:ValuationTechniqueDiscountedCashFlowMember2025-03-310001578732us-gaap:FairValueMeasurementsRecurringMembersrt:MinimumMembermmi:ContingentConsiderationMemberus-gaap:FairValueInputsLevel3Membermmi:ProbabilityOfAchievementMemberus-gaap:ValuationTechniqueDiscountedCashFlowMember2025-03-310001578732us-gaap:FairValueMeasurementsRecurringMembersrt:MaximumMembermmi:ContingentConsiderationMemberus-gaap:FairValueInputsLevel3Membermmi:ProbabilityOfAchievementMemberus-gaap:ValuationTechniqueDiscountedCashFlowMember2025-03-310001578732us-gaap:FairValueMeasurementsRecurringMembersrt:WeightedAverageMembermmi:ContingentConsiderationMemberus-gaap:FairValueInputsLevel3Membermmi:ProbabilityOfAchievementMemberus-gaap:ValuationTechniqueDiscountedCashFlowMember2025-03-310001578732mmi:ContingentConsiderationMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:ValuationTechniqueDiscountedCashFlowMember2024-12-310001578732us-gaap:FairValueMeasurementsRecurringMembersrt:MinimumMembermmi:ContingentConsiderationMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputExpectedTermMemberus-gaap:ValuationTechniqueDiscountedCashFlowMember2024-12-310001578732us-gaap:FairValueMeasurementsRecurringMembersrt:MaximumMembermmi:ContingentConsiderationMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputExpectedTermMemberus-gaap:ValuationTechniqueDiscountedCashFlowMember2024-12-310001578732us-gaap:FairValueMeasurementsRecurringMembersrt:WeightedAverageMembermmi:ContingentConsiderationMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputExpectedTermMemberus-gaap:ValuationTechniqueDiscountedCashFlowMember2024-12-310001578732us-gaap:FairValueMeasurementsRecurringMembersrt:MinimumMembermmi:ContingentConsiderationMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputDiscountRateMemberus-gaap:ValuationTechniqueDiscountedCashFlowMember2024-12-310001578732us-gaap:FairValueMeasurementsRecurringMembersrt:MaximumMembermmi:ContingentConsiderationMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputDiscountRateMemberus-gaap:ValuationTechniqueDiscountedCashFlowMember2024-12-310001578732us-gaap:FairValueMeasurementsRecurringMembersrt:WeightedAverageMembermmi:ContingentConsiderationMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputDiscountRateMemberus-gaap:ValuationTechniqueDiscountedCashFlowMember2024-12-310001578732us-gaap:FairValueMeasurementsRecurringMembersrt:MinimumMembermmi:ContingentConsiderationMemberus-gaap:FairValueInputsLevel3Membermmi:ProbabilityOfAchievementMemberus-gaap:ValuationTechniqueDiscountedCashFlowMember2024-12-310001578732us-gaap:FairValueMeasurementsRecurringMembersrt:MaximumMembermmi:ContingentConsiderationMemberus-gaap:FairValueInputsLevel3Membermmi:ProbabilityOfAchievementMemberus-gaap:ValuationTechniqueDiscountedCashFlowMember2024-12-310001578732us-gaap:FairValueMeasurementsRecurringMembersrt:WeightedAverageMembermmi:ContingentConsiderationMemberus-gaap:FairValueInputsLevel3Membermmi:ProbabilityOfAchievementMemberus-gaap:ValuationTechniqueDiscountedCashFlowMember2024-12-310001578732us-gaap:FairValueMeasurementsRecurringMembermmi:MeasurementInputWeightedAveragePremiumMembermmi:InvestmentsInConvertibleNotesMember2025-03-310001578732us-gaap:FairValueMeasurementsRecurringMembermmi:MeasurementInputWeightedAverageDiscountRateMembermmi:InvestmentsInConvertibleNotesMember2025-03-310001578732us-gaap:FairValueMeasurementsRecurringMembermmi:InvestmentsInConvertibleNotesMember2025-01-012025-03-310001578732us-gaap:FairValueMeasurementsRecurringMembermmi:MeasurementInputWeightedAverageTermMembersrt:MaximumMembermmi:InvestmentsInConvertibleNotesMember2025-03-310001578732us-gaap:FairValueMeasurementsRecurringMembermmi:MeasurementInputWeightedAverageTermMembersrt:MinimumMembermmi:InvestmentsInConvertibleNotesMember2025-03-310001578732mmi:UnvestedRestrictedStockMembermmi:TwoThousandAndThirteenOmnibusEquityAwardPlanMember2025-03-310001578732mmi:TwoThousandAndThirteenOmnibusEquityAwardPlanMembermmi:UnvestedRestrictedStockMemberus-gaap:SubsequentEventMember2025-04-042025-04-0400015787322022-08-0200015787322023-05-020001578732mmi:A2013OmnibusEquityAwardPlanMember2025-03-310001578732mmi:A2013OmnibusEquityAwardPlanMemberus-gaap:RestrictedStockUnitsRSUMembersrt:MinimumMember2025-01-012025-03-310001578732mmi:A2013OmnibusEquityAwardPlanMemberus-gaap:RestrictedStockUnitsRSUMembersrt:MaximumMember2025-01-012025-03-310001578732us-gaap:PerformanceSharesMembermmi:A2013OmnibusEquityAwardPlanMember2025-01-012025-03-310001578732mmi:A2013OmnibusEquityAwardPlanMemberus-gaap:StockOptionMember2025-01-012025-03-310001578732mmi:PerformanceUnitsMembermmi:A2013OmnibusEquityAwardPlanMember2025-03-310001578732us-gaap:StockAppreciationRightsSARSMembermmi:A2013OmnibusEquityAwardPlanMember2025-03-310001578732us-gaap:PerformanceSharesMembermmi:A2013OmnibusEquityAwardPlanMember2025-03-310001578732mmi:A2013OmnibusEquityAwardPlanMemberus-gaap:StockOptionMember2025-03-310001578732mmi:PerformanceUnitsMembermmi:A2013OmnibusEquityAwardPlanMember2025-01-012025-03-310001578732us-gaap:StockAppreciationRightsSARSMembermmi:A2013OmnibusEquityAwardPlanMember2025-01-012025-03-310001578732mmi:EmployeeStockPurchasePlanMember2013-01-012013-12-310001578732mmi:EmployeeStockPurchasePlanMember2024-02-012024-02-290001578732mmi:EmployeeStockPurchasePlanMember2023-10-012023-10-310001578732mmi:EmployeeStockPurchasePlanMember2013-12-310001578732mmi:EmployeeStockPurchasePlanMember2025-03-310001578732mmi:EmployeeStockPurchasePlanMember2024-01-012024-03-310001578732mmi:RestrictedStockAndRestrictedStockUnitsMember2025-01-012025-03-310001578732mmi:RestrictedStockAndRestrictedStockUnitsMember2024-01-012024-03-310001578732us-gaap:RestrictedStockMembermmi:TheAmendedPlanMember2025-01-012025-03-310001578732us-gaap:OperatingSegmentsMembermmi:RealEstateBrokerageCommissionsMembermmi:ReportableSegmentMember2025-01-012025-03-310001578732us-gaap:OperatingSegmentsMembermmi:RealEstateBrokerageCommissionsMembermmi:ReportableSegmentMember2024-01-012024-03-310001578732us-gaap:OperatingSegmentsMembermmi:FinancingFeesMembermmi:ReportableSegmentMember2025-01-012025-03-310001578732us-gaap:OperatingSegmentsMembermmi:FinancingFeesMembermmi:ReportableSegmentMember2024-01-012024-03-310001578732us-gaap:OperatingSegmentsMembermmi:OtherRevenuesMembermmi:ReportableSegmentMember2025-01-012025-03-310001578732us-gaap:OperatingSegmentsMembermmi:OtherRevenuesMembermmi:ReportableSegmentMember2024-01-012024-03-310001578732us-gaap:OperatingSegmentsMembermmi:ReportableSegmentMember2025-01-012025-03-310001578732us-gaap:OperatingSegmentsMembermmi:ReportableSegmentMember2024-01-012024-03-310001578732us-gaap:OperatingSegmentsMemberus-gaap:ServiceMembermmi:ReportableSegmentMember2025-01-012025-03-310001578732us-gaap:OperatingSegmentsMemberus-gaap:ServiceMembermmi:ReportableSegmentMember2024-01-012024-03-310001578732us-gaap:OperatingSegmentsMembermmi:SalesAndProductionSupportMembermmi:ReportableSegmentMember2025-01-012025-03-310001578732us-gaap:OperatingSegmentsMembermmi:SalesAndProductionSupportMembermmi:ReportableSegmentMember2024-01-012024-03-310001578732us-gaap:OperatingSegmentsMembermmi:FacilityExpensesMembermmi:ReportableSegmentMember2025-01-012025-03-310001578732us-gaap:OperatingSegmentsMembermmi:FacilityExpensesMembermmi:ReportableSegmentMember2024-01-012024-03-310001578732us-gaap:MaterialReconcilingItemsMember2025-01-012025-03-310001578732us-gaap:MaterialReconcilingItemsMember2024-01-012024-03-310001578732mmi:CreditFacilityMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMember2023-09-250001578732mmi:CreditFacilityMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMember2025-03-310001578732mmi:CreditFacilityMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMember2023-09-252023-09-250001578732mmi:CreditFacilityMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMember2025-01-012025-03-310001578732mmi:CreditFacilityMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMember2024-01-012024-03-310001578732us-gaap:SubsequentEventMember2025-04-012025-05-070001578732us-gaap:SubsequentEventMember2025-04-012025-05-020001578732mmi:StevenF.DeGennaroMember2025-01-012025-03-310001578732mmi:StevenF.DeGennaroMember2025-03-31
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
__________________________
FORM 10-Q
__________________________
(Mark One)
| | | | | |
☒ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended March 31, 2025
OR
| | | | | |
☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from___________to___________
Commission File Number: 001-36155
__________________________
MARCUS & MILLICHAP, INC.
(Exact name of registrant as specified in its Charter)
__________________________
| | | | | |
Delaware | 35-2478370 |
(State or Other Jurisdiction of Incorporation or Organization) | (I.R.S. Employer Identification No.) |
| |
23975 Park Sorrento, Suite 400 Calabasas, California | 91302 |
(Address of Principal Executive Offices) | (Zip Code) |
(818) 212-2250
(Registrant’s telephone number, including area code)
__________________________
Securities registered pursuant to Section 12(b) of the Act:
| | | | | | | | | | | | | | |
Title of each class | | Trading Symbol(s) | | Name of each exchange on which registered |
Common Stock, par value $0.0001 per share | | MMI | | New York Stock Exchange |
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by checkmark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
| | | | | | | | | | | |
Large accelerated filer | ☒ | Accelerated filer | ☐ |
Non-accelerated filer | ☐ | Smaller reporting company | ☐ |
Emerging growth company | ☐ | | |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
Number of shares of common stock, par value $0.0001 per share, of the registrant issued and outstanding as of May 2, 2025 was 38,976,875 shares.
MARCUS & MILLICHAP, INC.
TABLE OF CONTENTS
PART I. FINANCIAL INFORMATION
Item 1. Financial Statements
MARCUS & MILLICHAP, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands, except for shares and par value)
| | | | | | | | | | | |
| March 31, 2025 (unaudited) | | December 31, 2024 |
Assets | | | |
Current assets: | | | |
Cash, cash equivalents, and restricted cash (restricted cash of $10,675 and $10,678 at March 31, 2025 and December 31, 2024, respectively) | $ | 149,704 | | | $ | 153,445 | |
Commissions receivable | 13,468 | | | 18,804 | |
Prepaid expenses | 7,422 | | | 9,311 | |
Income tax receivable | 6,050 | | | 6,030 | |
Marketable debt securities, available-for-sale (amortized cost of $119,432 and $189,667 at March 31, 2025 and December 31, 2024, respectively, and $0 allowance for credit losses) | 119,381 | | | 189,667 | |
Advances and loans, net | 15,515 | | | 17,519 | |
Other assets, current | 13,563 | | | 15,543 | |
Total current assets | 325,103 | | | 410,319 | |
Property and equipment, net | 24,864 | | | 26,139 | |
Operating lease right-of-use assets, net | 80,712 | | | 81,120 | |
Marketable debt securities, available-for-sale (amortized cost of $61,827 and $52,366 at March 31, 2025 and December 31, 2024, respectively, and $0 allowance for credit losses) | 61,113 | | | 51,147 | |
Assets held in rabbi trust | 11,995 | | | 12,191 | |
Deferred tax assets, net | 57,468 | | | 48,080 | |
Goodwill and other intangible assets, net | 42,966 | | | 43,521 | |
Advances and loans, net | 173,933 | | | 173,657 | |
Other assets, non-current | 23,870 | | | 23,626 | |
Total assets | $ | 802,024 | | | $ | 869,800 | |
Liabilities and stockholders’ equity | | | |
Current liabilities: | | | |
Accounts payable and accrued expenses | $ | 9,573 | | | $ | 13,737 | |
Deferred compensation and commissions | 29,523 | | | 67,197 | |
| | | |
Operating lease liabilities | 18,789 | | | 18,522 | |
Accrued bonuses and other employee related expenses | 10,774 | | | 25,485 | |
Other liabilities, current | 17,588 | | | 8,076 | |
Total current liabilities | 86,247 | | | 133,017 | |
Deferred compensation and commissions | 26,160 | | | 33,257 | |
Operating lease liabilities | 65,152 | | | 65,701 | |
Other liabilities, non-current | 6,912 | | | 7,007 | |
Total liabilities | 184,471 | | | 238,982 | |
Commitments and contingencies | — | | | — | |
Stockholders’ equity: | | | |
Preferred stock, $0.0001 par value: | | | |
Authorized shares – 25,000,000; issued and outstanding shares – none at March 31, 2025 and December 31, 2024, respectively | — | | | — | |
Common stock, $0.0001 par value: | | | |
Authorized shares – 150,000,000; issued and outstanding shares – 39,138,040 and 38,856,790 at March 31, 2025 and December 31, 2024, respectively | 4 | | | 4 | |
Additional paid-in capital | 174,799 | | | 173,340 | |
Retained earnings | 443,830 | | | 458,907 | |
Accumulated other comprehensive loss | (1,080) | | | (1,433) | |
Total stockholders’ equity | 617,553 | | | 630,818 | |
Total liabilities and stockholders’ equity | $ | 802,024 | | | $ | 869,800 | |
See accompanying notes to condensed consolidated financial statements.
MARCUS & MILLICHAP, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share amounts)
(Unaudited)
| | | | | | | | | | | | | | | |
| Three Months Ended March 31, | | |
| 2025 | | 2024 | | | | |
Revenue: | | | | | | | |
Real estate brokerage commissions | $ | 123,622 | | | $ | 109,475 | | | | | |
Financing fees | 18,130 | | | 14,427 | | | | | |
Other revenue | 3,286 | | | 5,202 | | | | | |
Total revenue | 145,038 | | | 129,104 | | | | | |
Operating expenses: | | | | | | | |
Cost of services | 88,348 | | | 76,868 | | | | | |
Selling, general and administrative | 71,552 | | | 68,916 | | | | | |
Depreciation and amortization | 2,849 | | | 3,422 | | | | | |
Total operating expenses | 162,749 | | | 149,206 | | | | | |
Operating loss | (17,711) | | | (20,102) | | | | | |
Other income, net | 3,979 | | | 5,568 | | | | | |
Interest expense | (187) | | | (199) | | | | | |
Loss before benefit for income taxes | (13,919) | | | (14,733) | | | | | |
Benefit for income taxes | (9,497) | | | (4,746) | | | | | |
Net loss | $ | (4,422) | | | $ | (9,987) | | | | | |
| | | | | | | |
Net loss per share: | | | | | | | |
Basic | $ | (0.11) | | | $ | (0.26) | | | | | |
Diluted | $ | (0.11) | | | $ | (0.26) | | | | | |
Weighted average common shares outstanding: | | | | | | | |
Basic | 38,930 | | 38,447 | | | | |
Diluted | 38,930 | | 38,447 | | | | |
See accompanying notes to condensed consolidated financial statements.
MARCUS & MILLICHAP, INC.
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS
(in thousands)
(Unaudited)
| | | | | | | | | | | | | | | |
| Three Months Ended March 31, | | |
| 2025 | | 2024 | | | | |
| | | | | | | |
Net loss | $ | (4,422) | | | $ | (9,987) | | | | | |
Other comprehensive income (loss): | | | | | | | |
Marketable debt securities, available-for-sale: | | | | | | | |
Change in net unrealized gains and losses | 349 | | | (159) | | | | | |
Reclassification adjustment for net gains and losses included in other income, net | (6) | | | — | | | | | |
Net change, net of tax of $110 and $(49) for the three months ended March 31, 2025 and 2024, respectively | 343 | | | (159) | | | | | |
Foreign currency translation gain (loss), net of tax of $0 for each of the three months ended March 31, 2025 and 2024, respectively | 10 | | | (349) | | | | | |
Total other comprehensive income (loss) | 353 | | | (508) | | | | | |
Comprehensive loss | $ | (4,069) | | | $ | (10,495) | | | | | |
See accompanying notes to condensed consolidated financial statements.
MARCUS & MILLICHAP, INC.
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
(in thousands, except for shares)
(Unaudited)
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Three Months Ended March 31, 2025 |
| Preferred Stock | | Common Stock | | Additional Paid-in Capital | | Retained Earnings | | Accumulated Other Comprehensive (Loss) Income | | Total |
| Shares | | Amount | | Shares | | Amount | | | | |
Balance at December 31, 2024 | — | | | $ | — | | | 38,856,790 | | | $ | 4 | | | $ | 173,340 | | | $ | 458,907 | | | $ | (1,433) | | | $ | 630,818 | |
Net and comprehensive (loss) income | — | | | — | | | — | | | — | | | — | | | (4,422) | | | 353 | | | (4,069) | |
Dividends | — | | | — | | | — | | | — | | | — | | | (10,230) | | | — | | | (10,230) | |
Stock-based award activity | | | | | | | | | | | | | | | |
Stock-based compensation | — | | | — | | | — | | | — | | | 6,179 | | | — | | | — | | | 6,179 | |
| | | | | | | | | | | | | | | |
Issuance of common stock for vesting of restricted stock units | — | | | — | | | 426,884 | | | — | | | — | | | — | | | — | | | — | |
| | | | | | | | | | | | | | | |
Shares withheld related to net share settlement of stock-based awards | — | | | — | | | (133,096) | | | — | | | (4,720) | | | — | | | — | | | (4,720) | |
| | | | | | | | | | | | | | | |
Repurchases of common stock | — | | | — | | | (12,538) | | | — | | | — | | | (425) | | | — | | | (425) | |
Balance as of March 31, 2025 | — | | | $ | — | | | 39,138,040 | | | $ | 4 | | | $ | 174,799 | | | $ | 443,830 | | | $ | (1,080) | | | $ | 617,553 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Three Months Ended March 31, 2024 |
| Preferred Stock | | Common Stock | | Additional Paid-In Capital | | Retained Earnings | | Accumulated Other Comprehensive Loss | | Total |
| Shares | | Amount | | Shares | | Amount | | | | |
Balance at December 31, 2023 | — | | | $ | — | | | 38,412,484 | | $ | 4 | | | $ | 153,740 | | | $ | 492,298 | | | $ | (768) | | | $ | 645,274 | |
Net and comprehensive loss | — | | | — | | | — | | | — | | | — | | | (9,987) | | | (508) | | | (10,495) | |
Dividends | — | | | — | | | — | | | — | | | — | | | (10,087) | | | — | | | (10,087) | |
Stock-based award activity | | | | | | | | | | | | | | | |
Stock-based compensation | — | | | — | | | — | | | — | | | 5,795 | | | — | | | — | | | 5,795 | |
| | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
Issuance of common stock for vesting of restricted stock units | — | | | — | | | 366,559 | | | — | | | — | | | — | | | — | | | — | |
| | | | | | | | | | | | | | | |
Shares withheld related to net share settlement of stock-based awards | — | | | — | | | (128,540) | | | — | | | (4,378) | | | — | | | — | | | (4,378) | |
| | | | | | | | | | | | | | | |
Repurchases of common stock | — | | | — | | | (16,900) | | | — | | | — | | | (554) | | | — | | | (554) | |
Balance as of March 31, 2024 | — | | | $ | — | | | 38,633,603 | | $ | 4 | | | $ | 155,157 | | | $ | 471,670 | | | $ | (1,276) | | | $ | 625,555 | |
See accompanying notes to condensed consolidated financial statements.
MARCUS & MILLICHAP, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
(Unaudited)
| | | | | | | | | | | |
| Three Months Ended March 31, |
| 2025 | | 2024 |
Cash flows from operating activities | | | |
Net loss | $ | (4,422) | | | $ | (9,987) | |
Adjustments to reconcile net loss to net cash used in operating activities: | | | |
Depreciation and amortization | 2,849 | | | 3,422 | |
Non-cash lease expense | 5,416 | | | 5,649 | |
Credit loss expense | 44 | | | 134 | |
Stock-based compensation | 6,179 | | | 5,795 | |
Deferred taxes, net | (9,498) | | | (4,746) | |
Unrealized foreign exchange losses | 1 | | | 18 | |
Net realized losses on marketable debt securities, available-for-sale | (8) | | | — | |
Other non-cash items | 2,238 | | | (710) | |
Changes in operating assets and liabilities: | | | |
Commissions receivable | 5,342 | | | 2,192 | |
Prepaid expenses | 1,888 | | | 1,267 | |
Advances and loans | 1,687 | | | (4,304) | |
Other assets | 1,627 | | | (864) | |
Accounts payable and accrued expenses | (3,884) | | | 1,098 | |
Income tax receivable | (20) | | | (162) | |
Accrued bonuses and other employee related expenses | (14,703) | | | (11,840) | |
Deferred compensation and commissions | (42,316) | | | (34,159) | |
Operating lease liabilities | (5,145) | | | (4,934) | |
Other liabilities | (116) | | | 1,110 | |
Net cash used in operating activities | (52,841) | | | (51,021) | |
Cash flows from investing activities | | | |
| | | |
Purchases of marketable debt securities, available-for-sale | (61,265) | | | (66,045) | |
Proceeds from sales and maturities of marketable debt securities, available-for-sale | 119,924 | | | 47,083 | |
| | | |
| | | |
| | | |
Purchase of property and equipment | (1,491) | | | (2,639) | |
Net cash provided by (used in) investing activities | 57,168 | | | (21,601) | |
Cash flows from financing activities | | | |
Taxes paid related to net share settlement of stock-based awards | (4,720) | | | (4,378) | |
| | | |
Dividends paid | (697) | | | (592) | |
Principal payments on stock appreciation rights liability | (2,230) | | | (1,976) | |
| | | |
Cash paid for stock repurchases | (425) | | | (554) | |
Net cash used in financing activities | (8,072) | | | (7,500) | |
Effect of currency exchange rate changes on cash, cash equivalents, and restricted cash | 4 | | | (75) | |
Net decrease in cash, cash equivalents, and restricted cash | (3,741) | | | (80,197) | |
Cash, cash equivalents, and restricted cash at beginning of period | 153,445 | | | 170,753 | |
Cash, cash equivalents, and restricted cash at end of period | $ | 149,704 | | | $ | 90,556 | |
Supplemental cash flow disclosures: | | | |
Interest paid during the period | $ | 385 | | | $ | 492 | |
Income taxes paid, net | $ | 21 | | | $ | 162 | |
Supplemental disclosures of non-cash investing and financing activities: | | | |
Reduction of accrued bonuses and other employee related expenses in settlement of employee notes receivable | $ | 6 | | | $ | 13 | |
Unpaid purchases of property and equipment | $ | 269 | | | $ | 437 | |
Right-of-use assets obtained in exchange for operating lease liabilities | $ | 4,976 | | | $ | 8,541 | |
| | | |
Dividend payable | $ | 10,230 | | | $ | 10,088 | |
| | | |
See accompanying notes to condensed consolidated financial statements.
MARCUS & MILLICHAP, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
1. Description of Business, Basis of Presentation and Recent Accounting Pronouncements
Description of Business
Marcus & Millichap, Inc. (the “Company,” “Marcus & Millichap,” or “MMI”), a Delaware corporation, is a real estate services firm specializing in commercial real estate investment sales, financing services, research and advisory services. As of March 31, 2025, MMI operates over 80 offices in the United States and Canada through its wholly-owned subsidiaries, including the operations of Marcus & Millichap Capital Corporation.
Reorganization and Initial Public Offering
MMI was formed in June 2013 in preparation for the spin-off of Marcus & Millichap Real Estate Investment Services, Inc. (“MMREIS”), the real estate investment services business of Marcus & Millichap Company ("MMC"). Our initial public offering (“IPO”) was completed in November 2013. In connection with our IPO the shareholders of MMREIS contributed their shares of MMREIS to MMI in exchange for common stock of MMI.
Basis of Presentation
The financial information presented in the accompanying unaudited condensed consolidated financial statements, has been prepared in accordance with rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) for Quarterly Reports on Form 10-Q and Article 10-01 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. generally accepted accounting principles (“U.S. GAAP”) for complete financial statements. In the opinion of management, the accompanying unaudited condensed consolidated financial statements and notes include all adjustments (consisting only of normal recurring adjustments) necessary for a fair presentation of the condensed consolidated financial position, results of operations and cash flows for the periods presented. These unaudited condensed consolidated financial statements should be read in conjunction with the annual audited consolidated financial statements and notes thereto, including the Company’s accounting policies for the year ended December 31, 2024 included in the Company’s Annual Report on Form 10-K filed on February 27, 2025 with the SEC. The results of the three months ended March 31, 2025 are not necessarily indicative of the results to be expected for the year ending December 31, 2025, for other interim periods or for future years.
Consolidation
The accompanying condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.
Use of Estimates
The preparation of the condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the related disclosures at the date of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.
Concentrations of Credit Risk
Financial instruments that potentially subject the Company to a concentration of credit risk principally consist of cash, cash equivalents, and restricted cash, investments in marketable debt securities, available-for-sale, investments in strategic alliance partners (included under other assets, current and non-current), security deposits (included under other assets, non-current), and commissions receivable, net. Cash, cash equivalents, and restricted cash are placed with high-credit quality financial institutions and invested in high-credit quality money market funds and commercial paper. Concentrations and ratings of investments in marketable debt securities, available-for-sale are limited by the approved investment policy.
MARCUS & MILLICHAP, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
To reduce its credit risk, the Company monitors the credit standing of the financial institutions and money market funds that represent amounts recorded as cash, cash equivalents, and restricted cash. The Company historically has not experienced any significant losses related to cash, cash equivalents, and restricted cash.
In September 2021, the Company entered into a strategic alliance (“Strategic Alliance”) with M&T Realty Capital Corporation (“MTRCC”) pursuant to which the Company provides loan opportunities that may be funded through MTRCC’s Delegated Underwriting and Servicing Agreement (“DUS Agreement”) with the Federal National Mortgage Association (“Fannie Mae”) that requires MTRCC to guarantee a portion of each loan funded. On a loan-by-loan basis, the Company, at its option, can indemnify a portion of MTRCC’s guarantee obligation of loan opportunities presented to and closed by MTRCC through the DUS Agreement. The Company manages and limits the concentration of risk related to the guarantees assumed by monitoring the underlying property type, geographic location, credit of the borrowers, underlying debt service coverage, and loan to value ratios.
The Company derives its revenue from a broad range of real estate investors, owners, and users in the United States and Canada, none of which individually represents a significant concentration of credit risk. The Company maintains allowances, as needed, for estimated credit losses based on management’s assessment of the likelihood of collection. For the three months ended March 31, 2025 and 2024, no transaction represented 10% or more of total revenue. Further, while one or more transactions may represent 10% or more of commissions receivable at any reporting date, amounts due for brokerage and financing transactions are typically collected within 10 days of settlement and, therefore, do not expose the Company to significant credit risk.
During the three months ended March 31, 2025 and 2024, the Company’s Canadian operations represented 4.6% and 4.4% of total revenue, respectively.
During the three months ended March 31, 2025 and 2024, no office represented 10% or more of total revenue.
Revenue Recognition
The Company generates real estate brokerage commissions by acting as a broker for real estate owners or investors seeking to buy or sell interests in commercial properties and generates financing fees from securing financing on purchase transactions, from refinancing its clients’ existing mortgage debt and other ancillary fees associated with financing activities, including, but not limited to, debt and equity advisory services, loan sales, due diligence services, loan guarantee fees, loan performance fees and other consulting services.
Real Estate Brokerage Commissions
Contracts for representing buyers and sellers of real estate are negotiated on a transaction-by-transaction basis. The consideration associated with the successful outcome remains constrained until the completion of a transaction which happens at the close of escrow. At that time, the Company's performance is complete and the Company recognizes revenue related to the transaction.
Financing Fees
Contracts for representing potential borrowers are negotiated on a transaction-by-transaction basis. The consideration associated with the successful outcome remains constrained until the completion of a transaction which happens at the time the loan closes. At that time, the Company recognizes revenue related to the transaction. The Company’s fee arrangements, with an exception for guarantee obligations, do not include terms or conditions that require the Company to perform any service or fulfill any obligation once the loan closes.
Loan Performance Fees - For loans originated through the Strategic Alliance with MTRCC, the Company receives variable consideration in the form of loan performance fees based on a portion of the servicing fees expected to be received by MTRCC under the servicing contract for servicing the loan. As the Company is not obligated to perform any servicing functions and has no further obligations related to the transaction giving rise to the loan performance fees, the estimated value of the loan performance fees to be received is recorded at the time the loan closes and are collected over the estimated term of the related loan. Any changes in the estimate of loan performance fees to be received are recorded in revenue in the period the estimate changes.
MARCUS & MILLICHAP, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
Guarantee Obligations - For certain loans originated through the Strategic Alliance with MTRCC, the Company may agree, at its option, to indemnify MTRCC for a portion of MTRCC’s obligations for loans sold to the Federal National Mortgage Association (“Fannie Mae”). For these loans, the Company allocates a portion of the transaction price and records a loan guarantee obligation based on its fair value. Revenue for this stand-ready obligation is recorded on a straight-line basis over the term of the estimated guarantee period and is recorded in financing fees in the condensed consolidated statements of operations. The guarantee obligation is capped at 16.7% of any unpaid principal balance in excess of the value of the collateral securing such loan. For these loans, the Company is required to pledge cash in a restricted bank account in support of the guarantee obligation. The Company records an allowance for estimated losses related to the loans subject to the guarantee considering the risk characteristics of the loan, the loan's risk rating, historical loss experience, potential adverse situations affecting individual loans and other forecasted information as appropriate.
Other Revenue
Other revenue includes fees generated from consulting and advisory services, leasing, as well as fees from other ancillary services, and such fees are recognized when services are provided, or upon closing of the transaction or when the Company has no further performance obligations.
Stock-Based Compensation
The Company measures and records compensation expense for all stock-based awards made to employees, independent contractors and non-employee directors. Awards are issued under the Amended and Restated 2013 Omnibus Equity Incentive Plan (the “Plan”) and 2013 Employee Stock Purchase Plan (the “ESPP”).
For awards made to the Company’s employees, directors and independent contractors, the Company initially values restricted stock units (“RSUs”) and restricted stock awards (“RSAs”) based on the grant date closing price of the Company’s common stock. For awards with periodic vesting, the Company recognizes the related expense on a straight-line basis over the requisite service period for the entire award, subject to periodic adjustments to ensure that the cumulative amount of expense recognized through the end of any reporting period is at least equal to the portion of the grant date value of the award that has vested through that date. The Company accounts for forfeitures as they occur.
The Company has issued performance share units ("PSUs"), which are subject to a three-year cliff-vesting period, based on achievement of pre-determined performance targets. At the end of each reporting period, we evaluate the probability that the PSUs will vest. Compensation expense related to PSUs is recognized over the three-year performance period, based on the grant-date fair value and the probability that the pre-determined performance targets will be achieved. The Company accounts for forfeitures as they occur.
For shares issued under the ESPP, the Company determined that the ESPP was a compensatory plan and is required to expense the fair value of the awards over each six-month offering period. The Company estimates the fair value of these awards using the Black-Scholes option pricing model. The Company calculates the expected volatility based on the historical volatility of the Company’s common stock, the risk-free interest rate based on the U.S. Treasury yield curve in effect at the time of grant, both consistent with the term of the offering period. The Company includes a dividend yield based on the recurring semi-annual dividend. The Company accounts for forfeitures as they occur.
Recent Accounting Pronouncements
Pending Adoption
In October 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2023-06, Disclosure Improvements: Codification Amendments in Response to the SEC’s Disclosure Update and Simplification Initiative (“ASU 2023-06”). ASU 2023-06 was issued in response to the SEC’s final amendments in Release No. 33-10532, Disclosure Update and Simplification that updated and simplified disclosure requirements that the SEC believed were duplicative, overlapping, or outdated, and to align the requirements in the FASB Accounting Standards Codification (“Codification”) with the SEC’s disclosure requirements. The effective date for each amendment in ASU 2023-06 will be the date on which the SEC’s removal of that related disclosure from Regulation S-X or Regulation S-K becomes effective, with early adoption prohibited. If the SEC has not removed the applicable requirement from Regulation S-X or Regulation S-K by June 30, 2027, the pending content of the related amendment will be removed from the
MARCUS & MILLICHAP, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
Codification and will not become effective for any entity. The Company does not expect the adoption of ASU 2023-06 to have a material impact on its consolidated financial statements and related disclosures.
In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (“ASU 2023-09”), to require disaggregated information about a reporting entity’s effective tax rate reconciliation, as well as information on income taxes paid. The new requirements should be applied on a prospective basis with an option to apply them retrospectively. ASU 2023-09 is effective for annual periods beginning after December 15, 2024. The Company is evaluating the impact this ASU will have on its consolidated financial statements and related disclosures.
In March 2024, the FASB issued ASU 2024-02, Codification Improvements - Amendments to Remove References to the Concepts Statements (“ASU 2024-02”), which removes references to various FASB Concepts Statements in the guidance to simplify the Codification and draw a distinction between authoritative and nonauthoritative literature. ASU 2024-02 is effective on a prospective basis, with the option for retrospective application, for annual periods beginning after December 15, 2024. The Company does not expect the adoption of ASU 2024-02 to have a material impact on its consolidated financial statements and related disclosures.
In November 2024, the FASB issued ASU 2024-03 Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40). The new guidance is intended to provide investors enhanced disclosures and requires public entities to disaggregate key expense types. The update is effective for fiscal years beginning after December 15, 2026 and interim periods within fiscal years beginning after December 15, 2027, with early adoption permitted. The disclosure updates are required to be applied prospectively with the option for retrospective application. While the adoption is not expected to have an impact on our consolidated financial statements, it is expected to result in incremental disclosures within the footnotes to our consolidated financial statements.
2. Property and Equipment, Net
Property and equipment, net consisted of the following (in thousands):
| | | | | | | | | | | |
| March 31, 2025 | | December 31, 2024 |
Computer software and hardware equipment | $ | 53,144 | | | $ | 52,208 | |
Furniture, fixtures and equipment | 25,007 | | | 24,938 | |
Less: accumulated depreciation and amortization | (53,287) | | | (51,007) | |
| $ | 24,864 | | | $ | 26,139 | |
Depreciation expense for property and equipment was $2.3 million and $2.4 million for the three months ended March 31, 2025 and 2024, respectively.
MARCUS & MILLICHAP, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
3. Investments in Marketable Debt Securities, Available-for-Sale
Amortized cost, allowance for credit losses, gross unrealized gains (losses) in accumulated other comprehensive income (loss) and fair value of marketable debt securities, available-for-sale, by type of security consisted of the following (in thousands):
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| March 31, 2025 |
| Amortized Cost | | Allowance for Credit Losses | | Gross Unrealized Gains | | Gross Unrealized Losses | | Fair Value |
Short-term investments: | | | | | | | | | |
U.S. treasuries | $ | 26,298 | | | $ | — | | | $ | 3 | | | $ | — | | | $ | 26,301 | |
Corporate debt | 93,134 | | | — | | | 16 | | | (70) | | | 93,080 | |
| | | | | | | | | |
| $ | 119,432 | | | $ | — | | | $ | 19 | | | $ | (70) | | | $ | 119,381 | |
Long-term investments: | | | | | | | | | |
U.S. treasuries | $ | 825 | | | $ | — | | | $ | — | | | $ | (32) | | | $ | 793 | |
U.S. government sponsored entities | 979 | | | — | | | 11 | | | (58) | | | 932 | |
Corporate debt | 27,685 | | | — | | | 198 | | | (738) | | | 27,145 | |
Asset-backed securities (“ABS”) and other | 32,338 | | | — | | | 187 | | | (282) | | | 32,243 | |
| $ | 61,827 | | | $ | — | | | $ | 396 | | | $ | (1,110) | | | $ | 61,113 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| December 31, 2024 |
| Amortized Cost | | Allowance for Credit Losses | | Gross Unrealized Gains | | Gross Unrealized Losses | | Fair Value |
Short-term investments: | | | | | | | | | |
U.S. treasuries | $ | 29,515 | | | $ | — | | | $ | 20 | | | $ | (18) | | | $ | 29,517 | |
Corporate debt | 160,152 | | | — | | | 55 | | | (57) | | | 160,150 | |
| | | | | | | | | |
| $ | 189,667 | | | $ | — | | | $ | 75 | | | $ | (75) | | | $ | 189,667 | |
Long-term investments: | | | | | | | | | |
U.S. treasuries | $ | 819 | | | $ | — | | | $ | — | | | $ | (46) | | | $ | 773 | |
U.S. government sponsored entities | 996 | | | — | | | 3 | | | (70) | | | 929 | |
Corporate debt | 31,820 | | | — | | | 139 | | | (1,025) | | | 30,934 | |
ABS and other | 18,731 | | | — | | | 114 | | | (334) | | | 18,511 | |
| $ | 52,366 | | | $ | — | | | $ | 256 | | | $ | (1,475) | | | $ | 51,147 | |
The Company’s investments in marketable debt securities, available-for-sale, that have been in a continuous unrealized loss position, for which an allowance for credit losses has not been recorded, by type of security consisted of the following (in thousands):
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| March 31, 2025 |
| Less than 12 months | | 12 months or greater | | Total |
| Fair Value | | Gross Unrealized Losses | | Fair Value | | Gross Unrealized Losses | | Fair Value(1) | | Gross Unrealized Losses |
U.S. treasuries | $ | 5,961 | | | $ | — | | | $ | 778 | | | $ | (32) | | | $ | 6,739 | | | $ | (32) | |
U.S. government sponsored entities | — | | | — | | | 434 | | | (58) | | | 434 | | | (58) | |
Corporate debt | 56,346 | | | (21) | | | 22,510 | | | (787) | | | 78,856 | | | (808) | |
ABS and other | 8,076 | | | (50) | | | 3,783 | | | (232) | | | 11,859 | | | (282) | |
| $ | 70,383 | | | $ | (71) | | | $ | 27,505 | | | $ | (1,109) | | | $ | 97,888 | | | $ | (1,180) | |
MARCUS & MILLICHAP, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| December 31, 2024 |
| Less than 12 months | | 12 months or greater | | Total |
| Fair Value | | Gross Unrealized Losses | | Fair Value | | Gross Unrealized Losses | | Fair Value(1) | | Gross Unrealized Losses |
U.S. treasuries | $ | — | | | $ | — | | | $ | 10,050 | | | $ | (64) | | | $ | 10,050 | | | $ | (64) | |
U.S. government sponsored entities | — | | | — | | | 432 | | | (70) | | | 432 | | | (70) | |
Corporate debt | 15,654 | | | (46) | | | 25,520 | | | (1,036) | | | 41,174 | | | (1,082) | |
ABS and other | 6,393 | | | (70) | | | 4,333 | | | (264) | | | 10,726 | | | (334) | |
| $ | 22,047 | | | $ | (116) | | | $ | 40,335 | | | $ | (1,434) | | | $ | 62,382 | | | $ | (1,550) | |
(1)The fair value excludes accrued interest receivable.
Gross realized gains and losses from the sales of the Company’s marketable debt securities, available-for-sale, consisted of the following (in thousands):
| | | | | | | | | | | | | | | |
| Three Months Ended March 31, | | |
| 2025 | | 2024 | | | | |
Gross realized gains (1) | $ | 8 | | | $ | — | | | | | |
Gross realized losses (1) | $ | — | | | $ | — | | | | | |
(1)Recorded in other income, net in the condensed consolidated statements of operations. The cost basis of securities sold were determined based on the specific identification method.
The Company invests its excess cash in a diversified portfolio of fixed and variable rate debt securities to meet current and future cash flow needs. All investments are made in accordance with the Company’s approved investment policy. As of March 31, 2025, the portfolio had a weighted average credit rating of A+ and a weighted term to contractual maturity of 4.7 years. As of March 31, 2025, the Company had 138 securities in the portfolio representing an unrealized aggregate loss of $1.2 million, or 1% of amortized cost, and a weighted average credit rating of A+.
As of March 31, 2025, the Company performed an impairment analysis and determined an allowance for credit losses was not required. The Company determined that it did not have an intent to sell and it was not more likely than not that the Company would be required to sell any security based on its current liquidity position, or to maintain compliance with its investment policy, specifically as it relates to minimum credit ratings. The Company evaluated the securities with an unrealized loss considering severity of loss, credit ratings, specific credit events during the period since acquisition, overall likelihood of default, market sector, potential impact from the current economic environment, including interest rates, geopolitical unrest and a review of an issuer’s and securities’ liquidity and financial strength, as needed. The Company concluded that it would receive all scheduled interest and principal payments. The Company, therefore, determined qualitatively that the unrealized loss was related to changes in interest rates and other market factors and therefore no allowance for credit losses was required.
MARCUS & MILLICHAP, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
Amortized cost and fair value of marketable debt securities, available-for-sale, by contractual maturity consisted of the following (in thousands, except weighted average data):
| | | | | | | | | | | | | | | | | | | | | | | |
| March 31, 2025 | | December 31, 2024 |
| Amortized Cost | | Fair Value | | Amortized Cost | | Fair Value |
Due in one year or less | $ | 119,432 | | | $ | 119,381 | | | $ | 189,667 | | | $ | 189,667 | |
Due after one year through five years | 24,925 | | | 24,724 | | | 26,315 | | | 25,944 | |
Due after five years through ten years | 11,053 | | | 10,744 | | | 11,246 | | | 10,716 | |
Due after ten years | 25,849 | | | 25,645 | | | 14,805 | | | 14,487 | |
| $ | 181,259 | | | $ | 180,494 | | | $ | 242,033 | | | $ | 240,814 | |
Weighted average contractual maturity | | | 4.7 years | | | | 2.3 years |
Actual maturities may differ from contractual maturities because certain issuers have the right to prepay certain obligations with or without prepayment penalties.
4. Acquisitions, Goodwill and Other Intangible Assets
Goodwill is recorded as part of the Company’s acquisitions and primarily arose from the acquired assembled workforce and brokerage and financing sales platforms. The Company expects all of the goodwill to be tax deductible, with the tax-deductible amount of goodwill related to the contingent and deferred consideration to be determined once the cash payments are made to settle any contingent and deferred consideration. The goodwill resulting from acquisitions is allocated to the Company’s one reporting unit.
Goodwill and intangible assets, net consisted of the following (in thousands):
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| March 31, 2025 | | December 31, 2024 |
| Gross Carrying Amount | | Accumulated Amortization | | Net Book Value | | Gross Carrying Amount | | Accumulated Amortization | | Net Book Value |
Goodwill and intangible assets: | | | | | | | | | | | |
Goodwill | $ | 37,599 | | | $ | — | | | $ | 37,599 | | | $ | 37,597 | | | $ | — | | | $ | 37,597 | |
Intangible assets (1) | 19,125 | | | (13,758) | | | 5,367 | | | 19,123 | | | (13,199) | | | 5,924 | |
| $ | 56,724 | | | $ | (13,758) | | | $ | 42,966 | | | $ | 56,720 | | | $ | (13,199) | | | $ | 43,521 | |
(1)Total weighted remaining average amortization period was 3.3 years and 3.5 years as of March 31, 2025 and December 31, 2024, respectively. Intangible assets principally include non-compete agreements and customer relationships.
The Company recorded amortization expense for intangible assets of $0.6 million and $1.0 million for the three months ended March 31, 2025 and 2024, respectively.
The changes in the carrying amount of goodwill consisted of the following (in thousands):
| | | | | |
| Three Months Ended March 31, 2025 |
Beginning balance | $ | 37,597 | |
Additions from acquisitions | — | |
Impact of foreign currency translation | 2 | |
Ending balance | $ | 37,599 | |
MARCUS & MILLICHAP, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
Estimated amortization expense for intangible assets by year for the next five years and thereafter consisted of the following (in thousands):
| | | | | |
| March 31, 2025 |
Remainder of 2025 | $ | 1,556 | |
2026 | 1,387 | |
2027 | 1,214 | |
2028 | 1,210 | |
2029 | — | |
Thereafter | — | |
| $ | 5,367 | |
The Company evaluates goodwill for impairment annually in the fourth quarter. In addition to the annual impairment evaluation, the Company evaluates at least quarterly whether events or circumstances have occurred in the period subsequent to the annual impairment testing, which indicate that it is more likely than not an impairment loss has occurred. The Company evaluates its intangible assets that have finite useful lives whenever an event or change in circumstances indicates that the carrying value of the asset may not be recoverable.
As of March 31, 2025, the Company considered the impact of economic conditions and evaluated its goodwill and intangible assets for impairment testing. The Company estimated the recoverability of the intangible assets by comparing the carrying amount of each asset to the future undiscounted cash flows that the Company expects the asset to generate. The sum of the undiscounted expected future cash flows was greater than the carrying amount of the intangible assets. The Company concluded that as of March 31, 2025, there was no impairment of its intangible assets or goodwill.
5. Selected Balance Sheet Data
Allowances on Advances and Loans
Allowance for credit losses for advances and loans was $1.2 million as of each of March 31, 2025 and December 31, 2024.
Other Assets
Other assets consisted of the following (in thousands):
| | | | | | | | | | | | | | | | | | | | | | | |
| Current | | Non-Current |
| March 31, 2025 | | December 31, 2024 | | March 31, 2025 | | December 31, 2024 |
Security deposits | $ | — | | | $ | — | | | $ | 1,286 | | | $ | 1,300 | |
Employee notes receivable | 101 | | | 28 | | | 9 | | | 88 | |
Securities, held-to-maturity(1) | — | | | — | | | 9,500 | | | 9,500 | |
Loan performance fee receivable | 3,594 | | | 3,310 | | | 12,865 | | | 12,529 | |
Investments in convertible notes(2) | 6,401 | | | 6,347 | | | — | | | — | |
Other(3) | 3,467 | | | 5,858 | | | 210 | | | 209 | |
| $ | 13,563 | | | $ | 15,543 | | | $ | 23,870 | | | $ | 23,626 | |
(1)In connection with the Strategic Alliance with MTRCC, the Company held a $9.5 million Mandatorily Redeemable Fixed-Rate Cumulative Preferred Stock investment in MTRCC classified as held-to-maturity, which was scheduled to be redeemed on September 1, 2024. In anticipation of the redemptions, the Company purchased, and net settled, $9.5 million of Mandatorily Redeemable Fixed-Rate Cumulative Preferred Stock of MTRCC on August 26, 2024. The
MARCUS & MILLICHAP, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
new securities are classified as held-to-maturity, are expected to mature on August 26, 2027 and accrue interest based on the one-year treasury rate.
(2)The Company purchased convertible notes with principal balances aggregating $5.0 million during the fourth quarter 2023 in connection with strategic alliances with companies in the real estate sector. The convertible notes accrue interest at rates between 6% and 10%, are convertible into equity for premiums and mature in a weighted average of 0.49 years subject to extension at the option of the holders. The Company has elected to account for its investments in convertible notes under the fair value option; see Note 7 – "Fair Value Measurements" for additional information.
(3)Other primarily includes customer trust accounts and prepaid lease costs.
Deferred Compensation and Commissions
Deferred compensation and commissions consisted of the following (in thousands):
| | | | | | | | | | | | | | | | | | | | | | | |
| Current | | Non-Current |
| March 31, 2025 | | December 31, 2024 | | March 31, 2025 | | December 31, 2024 |
Stock appreciation rights (“SARs”) liability (1) | $ | 2,774 | | | $ | 2,603 | | | $ | 6,900 | | | $ | 9,518 | |
Commissions payable to investment sales and financing professionals | 26,090 | | | 63,952 | | | 11,016 | | | 15,608 | |
Deferred compensation liability (1) | 106 | | | 173 | | | 8,244 | | | 8,131 | |
Other | 553 | | | 469 | | | — | | | — | |
| $ | 29,523 | | | $ | 67,197 | | | $ | 26,160 | | | $ | 33,257 | |
(1)The SARs and deferred compensation liabilities become subject to payout at the time the participant is no longer considered a service provider. As a result of the retirement of certain participants, estimated amounts to be paid to participants within the next twelve months have been classified as current.
SARs Liability
Prior to the IPO, certain employees of the Company were granted SARs under a stock-based compensation program assumed by MMC. In connection with the IPO, the SARs agreements were revised, the MMC liability of $20 million for the SARs was frozen as of March 31, 2013 and was transferred to MMI through a capital distribution. The SARs liability will be settled with each participant in ten annual installments in January of each year upon retirement or termination from service, or in full upon consummation of a change in control of the Company.
Under the revised agreements, MMI is required to accrue interest on the outstanding balance beginning on January 1, 2014, at a rate based on the 10-year treasury note, plus 2%. The rate resets annually. The rates at January 1, 2025 and 2024 were 6.57% and 5.95%, respectively. MMI recorded interest expense related to this liability of $156,000 and $170,000 for the three months ended March 31, 2025 and 2024, respectively.
Estimated payouts within the next twelve months for participants that have separated from service have been classified as current. During the three months ended March 31, 2025 and 2024, the Company made total payments of $2.6 million and $2.5 million, respectively, consisting of principal and accumulated interest.
Commissions Payable
Certain investment sales and financing professionals can earn additional commissions after meeting certain annual revenue thresholds. These commissions are recognized as cost of services in the period in which they are earned as they relate to specific transactions closed. The Company may defer payment of certain commissions, at its election, for up to three years. Commissions that are not expected to be paid within 12 months are classified as long-term.
Deferred Compensation Liability
A select group of management is eligible to participate in the Marcus & Millichap Deferred Compensation Plan (the “Deferred Compensation Plan”). The Deferred Compensation Plan is a non-qualified deferred compensation plan that is intended to comply with Section 409A of the Internal Revenue Code and permits participants to defer compensation up to
MARCUS & MILLICHAP, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
the limits set forth in the Deferred Compensation Plan. Amounts are paid out generally when the participant is no longer a service provider; however, an in-service payout election is available to participants. Participants may elect to receive payouts as a lump sum or quarterly over a two to 15-year period. The Company elected to fund the Deferred Compensation Plan through Company-owned variable life insurance policies. The Deferred Compensation Plan is managed by a third-party institutional fund manager, and the deferred compensation and investment earnings are held as a Company asset in a rabbi trust, which is recorded in assets held in rabbi trust in the accompanying condensed consolidated balance sheets. The assets in the trust are restricted unless the Company becomes insolvent, in which case the trust assets are subject to the claims of the Company’s creditors. The Company may also, in its sole and absolute discretion, elect to withdraw at any time a portion of the trust assets by an amount by which the fair market value of the trust assets exceeds 110% of the aggregate deferred compensation liability represented by the participants’ accounts. Estimated payouts within the next twelve months for participants that have separated from service or elected an in-service payout have been classified as current. During the three months ended March 31, 2025 and 2024, the Company made total payments to participants of $143,000 and $71,000 respectively.
The assets held in the rabbi trust are carried at the cash surrender value of the variable life insurance policies, which represents its fair value. The net change in the carrying value of the assets held in the rabbi trust and the net change in the carrying value of the deferred compensation liability, each exclusive of additional contributions, distributions and trust expenses, consisted of the following (in thousands):
| | | | | | | | | | | | | | | |
| Three Months Ended March 31, | | |
| 2025 | | 2024 | | | | |
(Decrease) increase in the carrying value of the assets held in the rabbi trust (1) | $ | (163) | | | $ | 689 | | | | | |
Decrease (increase) in the net carrying value of the deferred compensation obligation (2) | $ | 232 | | | $ | (575) | | | | | |
(1)Recorded in other income, net in the condensed consolidated statements of operations.
(2)Recorded in selling, general and administrative expense in the condensed consolidated statements of operations.
Other Liabilities
Other liabilities consisted of the following (in thousands):
| | | | | | | | | | | | | | | | | | | | | | | |
| Current | | Non-Current |
| March 31, 2025 | | December 31, 2024 | | March 31, 2025 | | December 31, 2024 |
Deferred consideration | $ | 415 | | | $ | 411 | | | $ | — | | | $ | — | |
Contingent consideration | 4,041 | | | 4,614 | | | 171 | | | 117 | |
Dividends payable | 10,772 | | | 942 | | | 1,262 | | | 1,559 | |
| | | | | | | |
Loan guarantee obligation | 1,548 | | | 1,426 | | | 5,401 | | | 5,238 | |
Other | 812 | | | 683 | | | 78 | | | 93 | |
| $ | 17,588 | | | $ | 8,076 | | | $ | 6,912 | | | $ | 7,007 | |
6. Related-Party Transactions
Shared and Transition Services
Certain services are provided to the Company under a Transition Services Agreement (“TSA”) between MMC and the Company. The TSA is intended to provide certain services until the Company acquires these services separately. In addition, the Company charges MMC for certain shared licensing arrangements. Under the TSA, the Company received net charge-backs during the three months ended March 31, 2025 and 2024 of $7,900 and $10,600, respectively. These amounts are included in selling, general and administrative expense in the accompanying condensed consolidated statements of operations.
MARCUS & MILLICHAP, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
Brokerage and Financing Services with the Subsidiaries of MMC
MMC has wholly or majority owned subsidiaries that buy and sell commercial real estate properties. The Company performs certain brokerage and financing services related to transactions of the subsidiaries of MMC. For the three months ended March 31, 2025, the Company did not have any transactions with subsidiaries of MMC. For the three months ended March 31, 2024 the Company earned real estate brokerage commissions and financing fees of $730,000 from transactions with subsidiaries of MMC related to these services and incurred cost of services of $442,000 related to this revenue.
Operating Lease with MMC
The Company has an operating lease with MMC for a single-story office building located in Palo Alto, California, which expires in May 2032. The related operating lease cost was $291,000 for both the three months ended March 31, 2025 and 2024. Operating lease cost is included in selling, general and administrative expense in the accompanying condensed consolidated statements of operations. The related operating lease right-of-use asset, net and operating lease liability as of March 31, 2025 was $6.8 million and $7.5 million, respectively and as of December 31, 2024 was $7.0 million and $7.6 million, respectively.
Amounts due to (from) MMC
As of March 31, 2025 and December 31, 2024, the Company recorded a net receivable of $1,000 and net payable of $1,000 with MMC, respectively. These amounts are included in other assets, current and accounts payable and accrued expenses, respectively, in the accompanying condensed consolidated balance sheets.
Other
The Company makes advances to non-executive employees from time-to-time. At March 31, 2025 and December 31, 2024, the aggregate principal amount for employee notes receivable was $110,000 and $116,000, respectively, which is included in other assets in the accompanying condensed consolidated balance sheets. See Note 5 – “Selected Balance Sheet Data”.
As of March 31, 2025, George M. Marcus, the Company’s founder and Chairman, beneficially owned approximately 38% of the Company’s issued and outstanding common stock, including shares owned by Phoenix Investments Holdings, LLC and the Marcus Family Foundation II.
7. Fair Value Measurements
U.S. GAAP defines the fair value of a financial instrument as the amount that would be received from the sale of an asset in an orderly transaction between market participants at the measurement date. The Company is responsible for the determination of fair value and the supporting methodologies and assumptions. The Company uses various pricing sources and third parties to provide and validate the values utilized.
The degree of judgment used in measuring the fair value of financial instruments is generally inversely correlated with the level of observable valuation inputs. Financial instruments with quoted prices in active markets generally have more pricing observability and less judgment is used in measuring fair value. Financial instruments for which no quoted prices are available have less observability and are measured at fair value using valuation models or other pricing techniques that require more judgment.
Assets recorded at fair value are measured and classified in accordance with a fair value hierarchy consisting of the three “levels” based on the observability of inputs available in the marketplace used to measure the fair values as discussed below:
•Level 1: Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities;
•Level 2: Quoted prices in markets that are not active, or inputs which are observable, either directly or indirectly, for substantially the full term of the asset or liability; or
MARCUS & MILLICHAP, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
•Level 3: Unobservable inputs reflect management’s best estimate of what market participants would use in pricing the asset or liability at the measurement date. Consideration is given to the risk inherent in the valuation technique and the risk inherent in the inputs to the model. Management estimates include certain pricing models, discounted cash flow methodologies and similar techniques that use significant unobservable inputs.
Recurring Fair Value Measurements
The Company values its investments including commercial paper and floating net asset value money market funds recorded in cash, cash equivalents, and restricted cash, investments in marketable debt securities, available-for-sale, assets held in the rabbi trust, deferred compensation liability, contingent and deferred consideration and investments in convertible notes at fair value on a recurring basis.
Fair values for investments included in cash, cash equivalents, and restricted cash and marketable debt securities, available-for-sale were determined for each individual security in the investment portfolio and all securities are Level 1 or Level 2 measurements as appropriate.
Fair values for assets held in the rabbi trust and related deferred compensation liability were determined based on the cash surrender value of the Company-owned variable life insurance policies and underlying investments in the trust, and are Level 2 and Level 1 measurements, respectively.
Contingent consideration in connection with acquisitions, is carried at fair value and determined on a contract-by-contract basis, calculated using unobservable inputs based on a probability of achieving EBITDA and other performance requirements, and is a Level 3 measurement. Deferred consideration in connection with acquisitions is carried at fair value and calculated using a discounted cash flow estimate with the only remaining condition on such payments being the passage of time, and is a Level 2 measurement.
We have elected to account for our investments in convertible notes, included in other assets, under the fair value option, with changes in fair value recognized in other income, net in the condensed consolidated statements of operations. We estimate the fair value of each convertible note at each balance sheet date using a scenario-based framework that incorporates various scenarios weighted based on the expected likelihood of occurrence. Within each scenario, a discounted cash flow approach was utilized, taking the expected settlement for the event, and discounting it based on the expected timing and a discount rate. Each of the assumptions in the model were considered significant assumptions. We noted that a change in the expected probability, expected payoff, timing, or discount rate, would result in a change to the fair value ascribed to the convertible notes. As these are significant inputs not observable in the market, the valuation is classified as a Level 3 measurement.
MARCUS & MILLICHAP, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
Assets and liabilities carried at fair value on a recurring basis consisted of the following (in thousands):
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| March 31, 2025 | | December 31, 2024 |
| Fair Value | | Level 1 | | Level 2 | | Level 3 | | Fair Value | | Level 1 | | Level 2 | | Level 3 |
Assets: | | | | | | | | | | | | | | | |
Assets held in rabbi trust | $ | 11,995 | | | $ | — | | | $ | 11,995 | | | $ | — | | | $ | 12,191 | | | $ | — | | | $ | 12,191 | | | $ | — | |
Convertible notes | $ | 6,401 | | | $ | — | | | $ | — | | | $ | 6,401 | | | $ | 6,347 | | | $ | — | | | $ | — | | | $ | 6,347 | |
Cash equivalents (1): | | | | | | | | | | | | | | | |
Commercial paper | $ | 7,070 | | | $ | — | | | $ | 7,070 | | | $ | — | | | $ | — | | | $ | — | | | $ | — | | | $ | — | |
Money market funds | 79,483 | | | 79,483 | | | — | | | — | | | 90,737 | | | 90,737 | | | — | | | — | |
| $ | 86,553 | | | $ | 79,483 | | | $ | 7,070 | | | $ | — | | | $ | 90,737 | | | $ | 90,737 | | | $ | — | | | $ | — | |
Marketable debt securities, available-for-sale: | | | | | | | | | | | | | | | |
Short-term investments: | | | | | | | | | | | | | | | |
U.S. treasuries | $ | 26,301 | | | $ | 26,301 | | | $ | — | | | $ | — | | | $ | 29,517 | | | $ | 29,517 | | | $ | — | | | $ | — | |
Corporate debt | 93,080 | | | — | | | 93,080 | | | — | | | 160,150 | | | — | | | 160,150 | | | — | |
| | | | | | | | | | | | | | | |
| $ | 119,381 | | | $ | 26,301 | | | $ | 93,080 | | | $ | — | | | $ | 189,667 | | | $ | 29,517 | | | $ | 160,150 | | | $ | — | |
Long-term investments: | | | | | | | | | | | | | | | |
U.S. treasuries | $ | 793 | | | $ | 793 | | | $ | — | | | $ | — | | | $ | 773 | | | $ | 773 | | | $ | — | | | $ | — | |
U.S. government sponsored entities | 932 | | | — | | | 932 | | | — | | | 929 | | | — | | | 929 | | | — | |
Corporate debt | 27,145 | | | — | | | 27,145 | | | — | | | 30,934 | | | — | | | 30,934 | | | — | |
ABS and other | 32,243 | | | — | | | 32,243 | | | — | | | 18,511 | | | — | | | 18,511 | | | — | |
| $ | 61,113 | | | $ | 793 | | | $ | 60,320 | | | $ | — | | | $ | 51,147 | | | $ | 773 | | | $ | 50,374 | | | $ | — | |
Liabilities: | | | | | | | | | | | | | | | |
Contingent consideration | $ | 4,212 | | | $ | — | | | $ | — | | | $ | 4,212 | | | $ | 4,731 | | | $ | — | | | $ | — | | | $ | 4,731 | |
Deferred consideration | $ | 415 | | | $ | — | | | $ | 415 | | | $ | — | | | $ | 411 | | | $ | — | | | $ | 411 | | | $ | — | |
Deferred compensation liability | $ | 8,350 | | | $ | 8,350 | | | $ | — | | | $ | — | | | $ | 8,304 | | | $ | 8,304 | | | $ | — | | | $ | — | |
(1)Included in cash, cash equivalents, and restricted cash on the accompanying condensed consolidated balance sheets.
There were no transfers in or out of Level 3 during the three months ended March 31, 2025 and 2024.
During the three months ended March 31, 2025, the Company considered current and future interest rates and the probability of achieving EBITDA and other performance targets in its determination of fair value for the contingent consideration. The Company is uncertain as to the extent of the volatility in the unobservable inputs in the foreseeable future. Deferred consideration in connection with acquisitions is carried at fair value and calculated using a discounted cash flow estimate with the only remaining condition on such payments being the passage of time.
As of March 31, 2025 and December 31, 2024, contingent and deferred consideration had a maximum undiscounted payment to be settled in cash or stock of $12 million. Assuming the achievement of the applicable performance criteria and time requirements, the Company anticipates these payments will be made over the next one to two-year period. Changes in fair value are included in selling, general and administrative expense in the condensed consolidated statements of operations.
MARCUS & MILLICHAP, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
A reconciliation of contingent consideration measured at fair value on a recurring basis consisted of the following (in thousands):
| | | | | | | | | | | |
| Three Months Ended March 31, |
| 2025 | | 2024 |
Beginning balance | $ | 4,731 | | | $ | 5,482 | |
| | | |
Change in fair value of contingent consideration(1) | (519) | | | 180 | |
Payments of contingent consideration | — | | | — | |
Ending balance | $ | 4,212 | | | $ | 5,662 | |
(1)Includes immaterial impact of foreign currency translation.
Quantitative information about the valuation technique and significant unobservable inputs used in the valuation of the Company’s Level 3 financial liabilities measured at fair value on a recurring basis consisted of the following (dollars in thousands):
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Fair Value at March 31, 2025 | | Valuation Technique | | Unobservable inputs | | Range (Weighted Average)(1) |
Contingent consideration | $ | 4,212 | | | Discounted cash flow | | Expected life of cash flows | | 0-2.6 years | | (0.2 years) |
| | | | | Discount rate | | 4.1%-5.8% | | (5.6%) |
| | | | | Probability of achievement | | 0.1%-100.0% | | (98.9%) |
| | | | | | | | | |
| Fair Value at December 31, 2024 | | Valuation Technique | | Unobservable inputs | | Range (Weighted Average)(1) |
Contingent consideration | $ | 4,731 | | | Discounted cash flow | | Expected life of cash flows | | 0.3-2.8 years | | (0.4 years) |
| | | | | Discount rate | | 4.8%-6.1% | | (5.9%) |
| | | | | Probability of achievement | | 0.0%-100.0% | | (98.2%) |
(1)Unobservable inputs were weighted by the relative fair value of the instruments.
The fair value of the convertible notes considered (i) the contractual maturity which may be extended at the option of the holders, (ii) a weighted average premium at settlement of 118% upon a subsequent financing, equity financing or a change in control, and (iii) a weighted average discount rate of 14.3%. During the three months ended March 31, 2025, the fair value of the convertible notes increased by approximately $54,000, primarily due to accrued interest and the increase in the estimated time to settlement from a weighted average of 0.77 years to 0.83 years.
Nonrecurring Fair Value Measurements
In accordance with U.S. GAAP, from time to time, the Company measures certain assets at fair value on a nonrecurring basis. The Company reviews the carrying value of intangibles, goodwill and other assets for indications of impairment at least annually. When indications of potential impairment are identified, the Company may be required to determine the fair value of those assets and record an adjustment for the carrying amount in excess of the fair value determined. Any fair value determination would be based on valuation approaches, which are appropriate under the circumstances and utilize Level 2 and Level 3 measurements as required.
8. Stockholders’ Equity
Common Stock
As of March 31, 2025 and December 31, 2024, there were 39,138,040 and 38,856,790 shares of common stock, $0.0001 par value, issued and outstanding, which included unvested RSAs issued to non-employee directors, respectively. See Note 11 – “Loss per Share” for additional information.
MARCUS & MILLICHAP, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
On February 6, 2025, the Board of Directors declared a semi-annual regular dividend of $0.25 per share, or $10.2 million, with a payment date of April 4, 2025, to stockholders of record at the close of business on March 12, 2025. The compensation committee of the Company’s Board of Directors (“Compensation Committee”) granted dividend equivalents to all unvested grants as of the record date.
As of March 31, 2025, the dividend payable was $12.0 million, of which $9.8 million was paid on April 4, 2025 and $2.2 million of dividend equivalents related to unvested stock awards remain to be paid upon vesting of stock awards. The $12.0 million dividend payable is recorded in other liabilities in the condensed consolidated balance sheets, of which $1.3 million is classified as non-current. See Note 5 – “Selected Balance Sheet Data.”
Preferred Stock
The Company has 25,000,000 authorized shares of preferred stock with a par value $0.0001 per share. At March 31, 2025 and December 31, 2024, there were no preferred shares issued or outstanding.
Accumulated Other Comprehensive Loss
Amounts reclassified from accumulated other comprehensive loss are included as a component of other income, net or selling, general and administrative expense, as applicable, in the condensed consolidated statements of operations. The reclassifications were determined on a specific identification basis.
The Company has not provided for U.S. taxes on unremitted earnings of its foreign subsidiary as it is operating at a loss and has no earnings and profits to remit. As a result, deferred taxes were not provided related to the cumulative foreign currency translation adjustments.
Repurchases of Common Stock
On August 2, 2022, the Company's Board of Directors authorized a common stock repurchase program (the “Repurchase Program”) of up to $70 million. On May 2, 2023, the Company's Board of Directors approved an additional $70 million to repurchase common stock under the Repurchase Program. During the three months ended March 31, 2025, the Company repurchased and retired 12,538 shares of common stock for $0.4 million, at an average cost of $33.89 per share. As of March 31, 2025, $70.5 million remained authorized for repurchases under the Repurchase Program.
9. Stock-Based Compensation Plans
2013 Omnibus Equity Incentive Plan
The Company’s Board of Directors adopted the 2013 Omnibus Equity Incentive Plan (the “2013 Plan”) in October 2013. In February 2017, the Board of Directors amended and restated the 2013 Plan, which was approved by the Company’s stockholders in May 2017. In October 2023 and February 2024, the Board of Directors further amended the 2013 Plan to eliminate the term of the 2013 Plan and to make certain other best practice and administrative changes (the 2013 Plan, as amended, the “Amended Plan”). The Amended Plan was approved by the stockholders of the Company at the 2024 Annual Meeting of Stockholders.
Grants are made from time to time by the Compensation Committee at its discretion, subject to certain restrictions as to the number and value of shares that may be granted to any individual. In addition, non-employee directors receive annual grants under a Director Compensation Policy. The Compensation Committee, at its discretion, may credit dividend equivalents to certain unvested awards as provided in the Amended Plan. Any dividend equivalents credited to unvested awards are paid to the participant at the time the related grants vest. As of March 31, 2025, there were 2,660,279 shares available for future grants under the Amended Plan.
Awards Granted and Settled
Under the Amended Plan, the Company has issued RSAs to non-employee directors and RSUs to employees and independent contractors. RSAs vest on the earlier of the first anniversary of the date of grant or the next annual meeting of stockholders, subject to service requirements. RSUs generally vest in equal annual installments over a four to five-year
MARCUS & MILLICHAP, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
period from the date of grant or earlier as approved by the Compensation Committee. The Company has also issued PSUs under the Amended Plan, which are subject to a three-year cliff-vesting period, based on achievement of pre-determined performance targets. At the end of each reporting period, we evaluate the probability that the PSUs will vest. Compensation expense related to PSUs is recognized over the three-year performance period, based on the grant-date fair value and the probability that the pre-determined performance targets will be achieved. Dividend equivalents granted for unvested stock awards are paid at the time the stock awards vest. Any unvested awards and dividend equivalents are forfeited upon termination as a service provider. As of March 31, 2025, there were no issued or outstanding options or SARs under the Amended Plan.
During the three months ended March 31, 2025, 426,884 RSUs vested, with 133,096 shares of common stock withheld to pay applicable required employee statutory withholding taxes based on the market value of the shares on the vesting date. The shares withheld for taxes were returned to the share reserve and are available for future issuance in accordance with provisions of the Amended Plan. Unvested RSUs will be settled through the issuance of new shares of common stock.
Outstanding Awards
Activity under the Amended Plan consisted of the following (dollars in thousands, except weighted average per share data):
| | | | | | | | | | | |
| Shares | | Weighted- Average Grant Date Fair Value Per Share |
Nonvested shares at December 31, 2024(1) | 1,986,007 | | $ | 38.74 | |
Granted | 236,653 | | 37.95 | |
Granted, with vesting subject to performance targets | 74,916 | | 37.95 | |
Vested | (426,884) | | 39.85 | |
Forfeited/canceled | (9,514) | | 36.09 | |
Nonvested shares at March 31, 2025(1) | 1,861,178 | | $ | 38.32 | |
(1)Nonvested RSUs will be settled through the issuance of new shares of common stock.
As of March 31, 2025, the Company had unrecognized stock-based compensation relating to RSUs and RSAs of approximately $62.8 million, which is expected to be recognized over a weighted-average period of 3.1 years.
Employee Stock Purchase Plan
In 2013, the Company adopted the 2013 Employee Stock Purchase Plan (the “ESPP”). The ESPP is intended to qualify under Section 423 of the Internal Revenue Code and provides for consecutive, non-overlapping six-month offering periods. The offering periods generally start on the first trading day on or after May 15 and November 15 of each year. Qualifying employees may purchase shares of the Company stock at a discount based on the lower of the market price at the beginning or end of the offering period, subject to Internal Revenue Service (“IRS”) limitations. The Company determined that the ESPP was a compensatory plan and is required to expense the fair value of the awards over each six-month offering period.
In October 2023 and February 2024, the Board of Directors amended the ESPP to (i) eliminate the term of the ESPP such that the ESPP shall continue in effect until the ESPP is terminated by the Board of Directors or the Compensation Committee, (ii) eliminate the “evergreen” feature providing for annual increases in the number of shares reserved for issuance under the ESPP without stockholder approval, (iii) increase the discount qualifying employees may purchase shares of the Company stock to 15% based on the lower of the market price at the beginning or end of the offering period, subject to IRS limitations and (iv) make certain other best practice and administrative changes to the ESPP (the ESPP as amended, the “Amended ESPP”). The Amended ESPP was approved by the stockholders of the Company at the 2024 Annual Meeting of Stockholders.
MARCUS & MILLICHAP, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
The ESPP initially had 366,667 shares of common stock reserved, and 80,532 shares of common stock remain available for issuance under the Amended ESPP as of March 31, 2025. As of March 31, 2025, total unrecognized compensation cost related to the Amended ESPP was $29,000 and is expected to be recognized over a weighted average period of 0.12 years.
Summary of Stock-Based Compensation
Components of stock-based compensation are included in selling, general and administrative expense in the condensed consolidated statements of operations and consisted of the following (in thousands):
| | | | | | | | | | | | | | | |
| Three Months Ended March 31, | | |
| 2025 | | 2024 | | | | |
ESPP | $ | 58 | | | $ | 54 | | | | | |
RSUs, PSUs and RSAs | 6,121 | | | 5,741 | | | | | |
| $ | 6,179 | | | $ | 5,795 | | | | | |
10. Income Taxes
The Company provides for the effects of income taxes in interim financial statements based on the Company’s estimate of its annual effective tax rate for the full year, which is based on forecasted income by jurisdiction where the Company operates, adjusted for any tax effects of items that relate discretely to the period, if any. For the current quarter, the Company recognized an income tax benefit of $9.5 million, resulting in an effective tax rate of 68.2%. In the comparable period of 2024, the income tax benefit was $4.7 million, with an effective tax rate of 32.2%. The increase in the effective tax rate for the three months ended March 31, 2025, compared to the same period in 2024, is primarily attributed to non-deductible items, state income taxes, and changes in the valuation allowance. The Company’s effective tax rate of 68.2% is greater than the 21.0% federal statutory tax rate primarily due to non-deductible items and state income taxes.
MARCUS & MILLICHAP, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
11. Loss per Share
Basic and diluted loss per share for the three months ended March 31, 2025 and 2024, respectively consisted of the following (in thousands, except per share data):
| | | | | | | | | | | | | | | |
| Three Months Ended March 31, | | |
| 2025 | | 2024 | | | | |
Numerator (Basic and Diluted): | | | | | | | |
Net loss | $ | (4,422) | | | $ | (9,987) | | | | | |
Change in value for stock settled consideration(1) | 1 | | | 18 | | | | | |
Adjusted net loss | $ | (4,421) | | | $ | (9,969) | | | | | |
Denominator: | | | | | | | |
Basic | | | | | | | |
Weighted average common shares issued and outstanding | 38,946 | | 38,464 | | | | |
Deduct: Unvested RSAs (2) | (16) | | (17) | | | | |
Weighted average common shares outstanding | 38,930 | | 38,447 | | | | |
Basic loss per common share | $ | (0.11) | | | $ | (0.26) | | | | | |
Diluted | | | | | | | |
Weighted average common shares outstanding from above | 38,930 | | 38,447 | | | | |
Add: Dilutive effect of RSUs, RSAs & ESPP(3) | — | | — | | | | |
Add: Contingently issuable shares(1)(3) | — | | — | | | | |
Weighted average common shares outstanding | 38,930 | | 38,447 | | | | |
Diluted loss per common share | $ | (0.11) | | | $ | (0.26) | | | | | |
Antidilutive shares excluded from diluted loss per common share(4) | 1,031 | | 1,020 | | | | |
(1)Relates to contingently issuable stock settled consideration.
(2)RSAs were issued to the non-employee directors and will vest in full on the earlier of the first anniversary of the date of grant or the next annual meeting of stockholders, subject to service requirements. See Note 9 – “Stock-Based Compensation Plans” for additional information.
(3)Shares related to the Company's RSUs, RSAs, ESPP, and contingently issuable shares were excluded from the weighted average common shares outstanding for the three months ended March 31, 2025 and 2024 because inclusion of such shares would be antidilutive in a period of loss.
(4)Primarily pertaining to RSU grants to the Company’s employees and independent contractors.
MARCUS & MILLICHAP, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
12. Segment Information
The Company's single reportable segment, the commercial real estate services segment, derives revenues from customers by providing investment sales and financing services to investors in commercial real estate. The measure of segment assets is reported on the consolidated balance sheets as total assets.
The following table presents selected financial information with respect to the Company's single reportable segment for the three months ended March 31, 2025 and 2024, respectively (in thousands):
| | | | | | | | | | | | | | |
| | Three Months Ended March 31, |
| | 2025 | | 2024 |
Revenue: | | | | |
Real estate brokerage commissions | | $ | 123,622 | | | $ | 109,475 | |
Financing fees | | 18,130 | | | 14,427 | |
Other revenue | | 3,286 | | | 5,202 | |
Total revenue | | 145,038 | | | 129,104 | |
Less: | | | | |
Cost of services | | 88,348 | | | 76,868 | |
Sales and production support | | 48,693 | | | 45,599 | |
Facility expenses | | 8,759 | | | 9,289 | |
Depreciation and amortization | | 2,849 | | | 3,422 | |
Other segment items(1) | | 14,100 | | | 14,028 | |
Interest expense | | 187 | | | 199 | |
Other income | | (3,979) | | | (5,568) | |
Income tax benefit | | (9,497) | | | (4,746) | |
Total net expenses | | 149,460 | | | 139,091 | |
Segment net loss | | (4,422) | | | (9,987) | |
Adjustments and reconciling items | | — | | | — | |
Consolidated net loss | | $ | (4,422) | | | $ | (9,987) | |
| | | | |
Other specified segment disclosures: | | | | |
Interest income(2) | | $ | 4,019 | | | $ | 4,943 | |
Interest expense | | $ | 187 | | | $ | 199 | |
Other significant noncash items: | | | | |
Stock-based compensation(3) | | $ | 6,179 | | | $ | 5,795 | |
(1)Other segment items includes: costs related to sales events, licenses and subscriptions, promotion and marketing, recruitment and training, information technology, telecommunications, consulting and professional fees, legal expenses, insurance costs, and other general and administrative expenses.
(2)Interest income is included within the other income caption.
(3)Stock-based compensation is included within the sales & production support caption.
13. Commitments and Contingencies
Credit Agreement
On September 25, 2023, the Company executed the First Amendment to the Second Amended and Restated Credit Agreement with Wells Fargo Bank, National Association (the "Bank"), which provided for a $10 million line of credit and a maturity date of June 1, 2024. On May 30, 2024, the Company executed the Second Amendment to the Second Amended Restated Credit Agreement which extended the maturity date to June 1, 2025 (the “Credit Facility”).
MARCUS & MILLICHAP, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
The Company may borrow, repay and reborrow amounts under the Credit Facility until its maturity date, at which time all amounts outstanding under the Credit Facility must be repaid in full. Borrowings under the Credit Facility are available for general corporate purposes and working capital. The Credit Facility includes a $3 million sublimit for the issuance of standby letters of credit of which $1.1 million was utilized at March 31, 2025. Borrowings under the Credit Facility bear interest at the Daily Simple SOFR rate plus a spread of 175 basis points. In connection with the amendments to the Credit Agreement, the Company paid bank fees and other expenses, which are being amortized over the remaining term of the Credit Agreement. The Company pays a commitment fee of up to 0.5% per annum, payable quarterly, based on the amount of unutilized commitments under the Credit Facility. The amortization and commitment fees are included in interest expense in the accompanying condensed consolidated statements of operations and were $32,000 and $30,000 for the three months ended March 31, 2025 and 2024, respectively. As of March 31, 2025, there were no amounts outstanding under the Credit Agreement.
The Credit Facility contains customary covenants, including financial covenants, financial reporting requirements and events of default. Financial covenants require the Company, on a combined basis with its guarantors, to maintain total liquidity including cash and cash equivalents and marketable securities, held for sale of $100 million and an average daily cash balance of $35 million with the Bank, on a combined basis with all the guarantors, calculated as of the end of the month. In addition, the Credit Facility requires that $10 million of the minimum daily average cash deposits be held in a blocked account at the Bank, as cash collateral. The Credit Facility is secured by substantially all assets of the Company, including pledges of 100% of the stock or other equity interest of each subsidiary except for the capital stock of a controlled foreign corporation (as defined in the Internal Revenue Code), in which case no such pledge is required. As of March 31, 2025, the Company was in compliance with all financial and non-financial covenants and has not experienced any limitation in its operations as a result of the covenants. Our ability to borrow under our Credit Facility is limited by our ability to comply with its covenants or obtain necessary waivers.
Strategic Alliance
The Company, in connection with the Strategic Alliance with MTRCC, has agreed to provide loan opportunities that may be funded through MTRCC’s DUS Agreement with Fannie Mae. MTRCC's agreement with Fannie Mae requires MTRCC to guarantee a portion of each funded loan. On a loan-by-loan basis, the Company, at its option, can indemnify a portion of MTRCC’s guarantee obligation of loan opportunities presented to and closed by MTRCC. As of March 31, 2025, the Company has agreed to a maximum aggregate guarantee obligation of $326.3 million relating to loans with an unpaid balance of $2,011.9 million. The Company would be liable for its maximum aggregate guarantee obligation only if all of the loans for which it is providing a guarantee to MTRCC were to default and all of the collateral underlying these loans were determined to be without value at the time of settlement. As of March 31, 2025 and December 31, 2024, the Company has recorded an allowance for loss-sharing obligations of $159,000 and $174,000, respectively. As of March 31, 2025 and December 31, 2024, the Company pledged $675,000 and $678,000, respectively, in a restricted bank account in support of the guarantee obligation.
Other
In connection with certain agreements with investment sales and financing professionals, the Company may agree to advance amounts to such professionals upon reaching certain time and performance goals. Such commitments as of March 31, 2025 aggregated $8.2 million, of which $1.1 million has been paid subsequent to quarter end.
14. Subsequent Events
Between March 31, 2025 and May 2, 2025, the Company repurchased an additional 161,165 shares of common stock for $5.0 million pursuant to the stock repurchase program.
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
Unless the context requires otherwise, the words “Marcus & Millichap,” “MMI,” “we,” the “Company,” “us” and “our” refer to Marcus & Millichap, Inc., and its consolidated subsidiaries.
Forward-Looking Statements
This Quarterly Report on Form 10-Q includes forward-looking statements, including our expectations regarding the long-term outlook of the commercial real estate transaction market and our positioning within it, our belief relating to the Company’s long-term growth, our assessment of the key factors influencing the Company’s business outlook, including the expectation for future interest rate cuts or rising inflation and likely impact of such cuts or inflation on commercial real estate demand, and the execution of our capital return program, including a semi-annual dividend and stock repurchase program. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends affecting the financial condition of our business. Forward-looking statements should not be read as a guarantee of future performance or results and will not necessarily be accurate indications of the times at, or by, which such performance or results may be achieved. Forward-looking statements are based on information available at the time those statements are made and/or management’s good faith belief as of that time with respect to future events and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in or suggested by the forward-looking statements. Important factors that could cause such differences include, but are not limited to:
•general uncertainty in the capital markets, a worsening of economic conditions, and the rate and pace of economic recovery following an economic downturn;
•changes in our business operations;
•market trends in the commercial real estate market or the general economy, including the impact of inflation and changes to interest rates;
•our ability to attract and retain qualified senior executives, managers, and investment sales and financing professionals;
•the impact of forgivable loans and related expense resulting from the recruitment and retention of agents;
•the effects of increased competition on our business;
•our ability to successfully enter new markets or increase our market share;
•our ability to successfully expand our services and businesses and to manage any such expansions;
•our ability to retain existing clients and develop new clients;
•our ability to keep pace with changes in technology;
•any business interruption or technology failure, including cybersecurity risks and ransomware attacks, and any related impact on our reputation;
•changes in interest rates, availability of capital, tax laws, employment laws, tariffs and trade regulations, executive orders, or other government regulation affecting our business;
•our ability to successfully identify, negotiate, execute, and integrate accretive acquisitions; and
•other risk factors included under “Risk Factors” in our most recent Annual Report on Form 10-K.
In addition, in this Quarterly Report, the words “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “goal,” “expect,” “predict,” “potential,” “should,” and similar expressions, as they relate to our Company, our business and our management, are intended to identify forward-looking statements. In light of these risks and uncertainties, the forward-looking events and circumstances discussed in this Quarterly Report on Form 10-Q may not occur and actual results could differ materially from those anticipated or implied in the forward-looking statements.
Forward-looking statements speak only as of the date of this Quarterly Report on Form 10-Q. You should not put undue reliance on any forward-looking statements. We assume no obligation to update forward-looking statements to reflect actual results, changes in assumptions or changes in other factors affecting forward-looking information, except to the extent required by applicable laws. If we update one or more forward-looking statements, no inference should be drawn that we will make additional updates with respect to those or other forward-looking statements.
The results of operations for the three months ended March 31, 2025 are not necessarily indicative of the results that may be expected for the full year ending December 31, 2025, or for any other future period. The following discussion should be read in conjunction with the unaudited condensed consolidated financial statements and the notes thereto included in Item 1 of this Quarterly Report on Form 10-Q and in conjunction with our Annual Report on Form 10-K for the year ended December 31, 2024, filed with the SEC on February 27, 2025, including the “Risk Factors” section and the consolidated financial statements and notes included therein.
Overview
We are a leading national real estate services firm specializing in commercial real estate investment sales, financing services, research and advisory services. We have been the top commercial real estate investment broker in the United States based on the number of investment transactions for more than 15 years. As of March 31, 2025, we had 1,668 investment sales and financing professionals that are primarily exclusive independent contractors operating in more than 80 offices, who provide real estate brokerage and financing services to sellers and buyers of commercial real estate assets. During the three months ended March 31, 2025, we closed 1,706 investment sales, financing and other transactions with total sales volume of approximately $9.4 billion. During the year ended December 31, 2024, we closed 7,836 investment sales, financing and other transactions with total sales volume of approximately $49.6 billion.
We generate revenue by collecting real estate brokerage commissions upon the sale, and financing fees upon the financing of commercial properties, by providing equity advisory services and loan sales, loan guarantees and by providing leasing, consulting and advisory services. Real estate brokerage commissions are typically based upon the value of the property and financing fees are typically based upon the size of the loan. During the three months ended March 31, 2025, approximately 85% of our revenue was generated from real estate brokerage commissions, 13% from financing fees and 2% from other real estate related services.
We divide commercial real estate into four major markets, characterized by price:
•Properties priced less than $1 million;
•Private client market: properties priced from $1 million to up to but less than $10 million;
•Middle market: properties priced from $10 million to up to but less than $20 million; and
•Larger transaction market: properties priced from $20 million and above.
We are the industry leader in serving private clients in the $1 million - $10 million private client market, which contributed approximately 63% and 67% of our real estate brokerage commissions during the three months ended March 31, 2025 and 2024, respectively. The following table sets forth the number of transactions, sales volume and revenue by each commercial real estate market for real estate brokerage:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Three Months Ended March 31, | | |
| 2025 | | 2024 | | Change |
Real Estate Brokerage | Number | | Volume | | Revenue | | Number | | Volume | | Revenue | | Number | | Volume | | Revenue |
| | | (in millions) | | (in thousands) | | | | (in millions) | | (in thousands) | | | | (in millions) | | (in thousands) |
<$1 million | 199 | | $ | 123 | | | $ | 5,026 | | | 186 | | $ | 103 | | | $ | 4,764 | | | 13 | | $ | 20 | | | $ | 262 | |
Private Client Market ($1 – <$10 million) | 832 | | 2,688 | | | 77,705 | | | 808 | | 2,590 | | | 73,163 | | | 24 | | 98 | | | 4,542 | |
Middle Market ($10 – <$20 million) | 85 | | 1,202 | | | 20,889 | | | 59 | | 802 | | | 15,093 | | | 26 | | 400 | | | 5,796 | |
Larger Transaction Market (≥$20 million) | 59 | | 2,646 | | | 20,003 | | | 49 | | 2,166 | | | 16,455 | | | 10 | | 480 | | | 3,548 | |
| 1,175 | | $ | 6,659 | | | $ | 123,623 | | | 1,102 | | $ | 5,661 | | | $ | 109,475 | | | 73 | | $ | 998 | | | $ | 14,148 | |
Factors Affecting Our Business
Our business and our operating results, financial condition and liquidity are significantly affected by the number and size of commercial real estate investment sales and financing transactions that we close in any period. The number and size of these transactions are affected by our ability to recruit and retain investment sales and financing professionals, identify and contract properties for sale, and identify those that need financing and refinancing. We principally monitor the commercial real estate market through four factors, which generally drive our business. The factors are the economy, commercial real estate supply and demand, capital markets, and investor sentiment and investment activity.
The Economy
Our business is dependent on economic conditions within the markets in which we operate. Changes in the economy on a global, national, regional, or local basis can have a positive or negative impact on our business. Economic indicators and projections related to job growth, unemployment, interest rates, retail spending and consumer confidence trends can have a positive or negative impact on our business. Overall market conditions, including global trade, interest rate changes, inflation, job creation, and global events can affect investor sentiment and, ultimately, the demand for our services from investors in real estate.
Overall economic performance was sound in the first quarter of 2025, with low unemployment and the addition of 456,000 new jobs. Retail sales remained active and inflation trended lower. Entering the second quarter of 2025, however, economic uncertainty increased dramatically as the U.S. reset its global trade policies with dramatic tariff increases. The resulting financial market volatility, falling consumer sentiment and general uncertainty have spurred increased caution among both consumers and businesses. Elevated caution may cause businesses and consumers to limit investment and spending as a potential trade war could weaken economic growth and spur inflation. Although most of the punitive tariffs were put on hold for 90 days, 10% tariffs on all countries aside from China, which faces 145% tariffs, has driven the net effective tariff rate to approximately 28%, the highest level since 1901. Limited insights into future trade policy has impacted decision making, increasing the risk of slowing economic growth.
The lack of clarity of the U.S. presidential administration regarding tariffs has made it increasingly difficult to predict the economic outlook, and many economists have raised their expectations of both recession and inflation risk in 2025. Nonetheless, some signs of a pullback on tariffs have emerged, suggesting that a trade war may be averted, which could revive the outlook for economic growth.
Within the broader economic context, commercial real estate fundamentals remain sturdy, with most property types delivering positive space absorption. Apartment demand remained robust through the first quarter of 2025, exceeding elevated construction completions and supporting modest but positive rent gains. Retail space demand was marginally negative for the quarter, but the resulting uptick in vacancy was minimal and may simply reflect a temporary market recalibration. Industrial space demand was positive for the quarter, and office space demand continued to gain momentum.
Commercial Real Estate Supply and Demand
Our business is dependent on the willingness of investors to invest in or sell commercial real estate, which is affected by many factors beyond our control. These factors include the supply of commercial real estate, coupled with user demand for these properties, and the performance of real estate assets, when compared with other investment alternatives, such as stocks and bonds.
Although apartment and industrial construction remains elevated, the supply additions are concentrated in select markets and the pace of deliveries is tapering. Oversupply risks in most markets are beginning to diminish as elevated capital costs join rising tariffs on building materials and construction labor shortages to drive construction costs higher. Retail and office development was already low entering 2025, with little sign of a revival. Apartment starts have fallen by 76% from their peak in 2022 and industrial completions in 2025 are expected to fall to approximately 210 million square feet, their lowest level since 2014. As a result, receding new supply risks in 2025 should aid commercial real estate performance in the coming quarters.
The commercial real estate space demand outlook for 2025 remains uncertain. Core drivers including job creation, retail sales and modest gains in office attendance entering the second quarter of 2025 suggest positive momentum, but the broader economic climate could impact the trajectory either positively or negatively. If the U.S. economy enters a recession, space demand for all types of commercial real estate could be negatively impacted. However, if a trade war is averted and sentiment increases, space demand could be bolstered.
All four major property types saw positive space demand in the fourth quarter of 2024 and in the year ended December 31, 2024. Nearly 660,000 apartment units were filled in 2024, the second strongest annual total in the 32 years on record. Apartment demand sustained momentum in the first quarter of 2025 with nearly 147,000 net units filled, the strongest first quarter on record. Office space demand was also positive in the first quarter of 2025, marking the fourth consecutive quarter of gains. This has helped reduce the office vacancy rate by 50 basis points from its peak of 17.2% set in the second quarter of 2024 spurring speculation that a slow recovery of the office market is occurring. Industrial space demand also remained positive, but the pace of absorption was overshadowed by new completions. Following 17 consecutive quarters of positive demand, retail space absorption fell in the first quarter of 2025, pushing the average
vacancy rate up by 10 basis points to 4.5%, still well below the twenty-year average of 5.6%. The retail space demand slowdown may reflect a temporary moderation of expansion plans by retailers ahead of tariff and trade war risks or it could simply reflect the limited availability of retail space.
The commercial real estate space demand outlook remains difficult to discern amid the dramatic policy shifts enacted by the new U.S. presidential administration. Increased uncertainty, falling sentiment and risks of a recession and higher inflation could slow decision making, causing commercial real estate space demand to falter. If the trade war deescalates and policy clarity emerges, commercial real estate space demand could be reinvigorated. Nonetheless, all commercial real estate property types have entered the new cycle on sound footing, suggesting a durable performance outlook.
Capital Markets
Credit and liquidity issues in the financial markets have a direct impact on the flow of capital to the commercial real estate market. Real estate purchases are often financed with debt, and as a result, credit and liquidity impact transaction activity and prices. Movements of interest rates in one direction, whether increasing or decreasing, could adversely or positively affect the operations and income potential of commercial real estate properties, as well as lender and equity underwriting for real estate investments. These changes directly influence investor demand for commercial real estate investments and what they are willing to pay. Furthermore, the use of debt or loan-to-value ratios can shift along with lender confidence and underwriting standards. At times of heightened uncertainty or liquidity issues, loan-to-values decline, requiring buyers to provide more equity and take more risk to close deals.
Although interest rates had been trending lower entering 2025, the recent economic turmoil driven by aggressive trade policies has spurred increased interest rate volatility. Interest rate risks were exacerbated by President Trump’s threats to remove Jerome Powell as the head of the Federal Reserve, risking the independence of the Federal Reserve. While lender spreads had been tightening, the rising risk of inflation, policy uncertainty and financial market volatility have led to increased lender caution. Although debt capital liquidity remains strong, many lenders have increased their safety spreads, resulting in a modest increase in lending rates.
The combination of limited federal policy transparency and inflation risks posed by tariffs have caused the Federal Reserve to await further clarity before making any decisions on monetary policy. The prevailing sentiment by Wall Street is that the Federal Reserve will cut rates two or three times this year, but Chairman Powell has clearly stated that until clarity emerges, they will likely hold the overnight rate flat. Nonetheless, the Federal Reserve’s influence on longer term rates like the 10-year treasury, which more directly influence commercial real estate lending rates, is limited. Following the institution of the “Liberation Day” tariffs, international capital began to migrate out of U.S. bonds and financial assets, putting upward pressure on interest rates. Looking forward, long-term rates may be more influenced by international capital flows and treasury issuance than by the Federal Reserve.
Although economic uncertainty together with financial market and interest rate volatility normally tend to increase investor caution, capital flows into commercial real estate could potentially be bolstered. As a “hard asset” with some level of resistance to inflation, recessions and financial market volatility, investment into commercial real estate could benefit from the current economic climate. The repricing of commercial real estate assets over the last three years has enhanced the yield profile, supporting positive or neutral leverage in many markets and property types. Whether capital migrates to commercial properties will likely depend on the risk perception of the broader financial market, but other hard assets have already experienced increased demand in the wake of the rapid policy shifts and financial market downturn.
Investor Sentiment and Investment Activity
We facilitate investors buying, selling, and financing properties in order to generate commissions. Investors’ desires and need to engage in real estate transactions are dependent on many factors that are beyond our control. The economy, supply and demand for properly positioned properties, available credit and market events impact investor sentiment and, therefore, transaction velocity. In addition, our private clients, who make up the largest source of revenue, are often motivated to buy, sell and/or refinance properties due to personal circumstances, such as death, divorce, partnership breakups and estate planning.
In the first quarter of 2025, commercial real estate transaction activity increased by 7% compared to the same quarter last year, led by velocity gains in seniors housing, retail and industrial property sales. Apartment transactions increased by 8% on a year-over-year basis, while office and hotel property sales activity declined. The transaction uptick reflects a narrowing of the expectation gap that began in the fourth quarter last year, but recent financial market volatility and
uncertainty surrounding trade and the economy as a whole could re-widen expectations. Clarity on investor expectations in the new trade and economic climate have yet to fully emerge.
Several metrics traditionally associated with rising transaction activity velocity, including increased exclusive inventory being brought to market and rising requests for Broker Opinions of Value, suggest that transactional momentum could be sustained in the coming quarters. Nonetheless, the variety of potential headwinds facing the sector including the economy, interest rates, financial market trends, geopolitical and commercial real estate pricing clarity could ultimately suppress activity in 2025. In the current uncertain climate, defensive assets such as single-tenant net lease properties backed by high-credit tenants and medical office assets continue to receive buyer interest. Apartment properties, supported by positive long-term drivers including robust demographics of the renter-aged population and the high cost of homeownership is also a favored property segment. Another important factor influencing the investor outlook is the prospective renewal of the 2017 Tax Cuts and Jobs Act which includes several tax benefits that are supportive of commercial real estate investment including accelerated depreciation, pass-through entity deductions and Opportunity Zones. Ultimately, market velocity will be dictated by a combination of the economic outlook, financial market trends, geopolitical forces, Federal Reserve action, interest rates and the buyer/seller expectation gap. If trade policy stabilizes, uncertainty abates and investor sentiment rises, we believe commercial real estate investment activity could gain additional momentum.
Key Financial Measures and Indicators
Revenue
Our revenue is primarily generated from our real estate investment sales business. In addition to real estate brokerage commissions, we generate revenue from financing fees and from other revenue, which are primarily comprised of leasing, consulting and advisory fees.
Because our business is transaction oriented, we rely on investment sales and financing professionals to continually develop leads, identify properties to sell and finance, market those properties and close the sale timely to generate a consistent flow of revenue. While our sales volume is impacted by seasonality factors, the timing of closings is also dependent on many market and personal factors unique to a particular client or transaction, particularly clients transacting in the $1 million to $10 million private client market. These factors can cause transactions to be accelerated or delayed beyond our control. Further, commission rates earned are generally inversely related to the value of the property sold. As a result of our expansion into the middle and larger transaction markets, we have seen our overall commission rates fluctuate from period-to-period as a result of changes in the relative mix of the number and volume of investment sales transactions closed in the middle and larger transaction markets as compared to the $1 million to $10 million private client market. These factors may result in period-to-period variations in our revenue that differ from historical patterns.
A small percentage of our transactions include retainer fees and/or breakage fees. Retainer fees are credited against a success-based fee paid upon the closing of a transaction or a breakage fee. Transactions that are terminated before completion will sometimes generate breakage fees, which are usually calculated as a set amount or a percentage of the fee we would have received had the transaction closed.
Real Estate Brokerage Commissions
We earn real estate brokerage commissions by acting as a broker for commercial real estate owners seeking to sell or investors seeking to buy properties. Revenue from real estate brokerage commissions is recognized at the close of escrow.
Financing Fees
We earn financing fees by securing financing on purchase transactions or by securing refinancing of our clients’ existing mortgage debt. We recognize financing fee revenue at the time the loan closes, and we have no remaining significant obligations in connection with the transaction.
To a lesser extent, we also earn fees on loan performance, equity advisory services, loan sales, loan guarantees and ancillary services associated with financing activities. We recognize guarantee fees over the term of the guarantee and other fees when we have no further performance obligations, generally upon the closing of a transaction.
Other Revenue
Other revenue includes fees generated from leasing, consulting and advisory services, as well as ancillary fees from other real estate brokers, and are recognized when services are provided, upon closing of the transaction or when we have no further performance obligations.
Operating Expenses
Our operating expenses consist of cost of services, selling, general and administrative expenses and depreciation and amortization. The significant components of our expenses are further described below.
Cost of Services
The majority of our cost of services expense is variable commissions paid to our investment sales and financing professionals and compensation-related costs related to our financing activities. Commission expenses are directly attributable to providing services to our clients for investment sales and financing services. Most of our investment sales and financing professionals are independent contractors and are paid commissions; however, because there are some who are initially paid a salary and certain of our financing professionals are employees, costs of services also include employee-related compensation, employer taxes and benefits for those employees. The commission rates we pay to our investment sales and financing professionals vary based on individual contracts negotiated and are generally higher for the more experienced professionals. Some of our most senior investment sales and financing professionals can also earn additional commissions after meeting certain annual financial thresholds. These additional commissions are recognized as cost of services in the period in which they are earned. Payment of a portion of these additional commissions are generally deferred for a period of three years, at our election, and paid at the end of the third calendar year. Cost of services also includes referral fees paid to other real estate brokers where we are the principal service provider. Cost of services, therefore, can vary based on the commission structure of the independent contractors that closed transactions in any particular period.
Selling, General and Administrative Expenses
The largest expense component within selling, general and administrative expenses is personnel expenses for our management team and sales and support staff, as well as business development, marketing, and expensing of forgivable loans over the retention period of our sales and financing professionals. In addition, these costs include facilities costs (excluding depreciation and amortization), staff related expenses, sales, marketing, legal, telecommunication, network, data sources, changes in fair value for contingent and deferred consideration and other administrative expenses. Also included in selling, general and administrative are expenses for stock-based compensation to non-employee directors, employees and independent contractors (i.e. investment sales and financing professionals) under the Amended and Restated 2013 Omnibus Equity Incentive Plan (the “Amended Plan”) and the Amended and Restated 2013 Employee Stock Purchase Plan (the “Amended ESPP”).
Depreciation and Amortization Expense
Depreciation expense consists of depreciation recorded on our computer software and hardware, as well as our furniture, fixtures and equipment. Depreciation is recognized over estimated useful lives ranging from three to seven years for assets. Amortization expense consists of amortization recorded on intangible assets amortized on a straight-line basis using a useful life between one and seven years.
Other Income, Net
Other income, net primarily consists of interest income, realized gains and losses on our marketable debt securities, available-for-sale, net gains or losses on our deferred compensation plan assets, foreign currency gains and losses and other non-operating income and expenses.
Interest Expense
Interest expense primarily consists of interest expense associated with the stock appreciation rights (“SARs”) liability, and our credit agreement.
Benefit for Income Taxes
We are subject to U.S. and Canadian federal taxes and individual state and local taxes based on the income generated in the jurisdictions in which we operate. Our effective tax rate fluctuates as a result of (i) changes in our annual effective tax rate applied to current pre-tax income (loss), (ii) the change in the mix of our activities in the jurisdictions in which we operate due to differing tax rates in those jurisdictions and (iii) the impact of permanent items, including compensation charges, qualified transportation fringe benefits, uncertain tax positions, meals and entertainment and tax-exempt deferred compensation plan assets. Our benefit for income taxes includes the windfall tax benefits and shortfall expenses, net, from shares issued in connection with our Amended Plan and Amended ESPP.
We record deferred taxes, net based on the tax rate expected to be in effect at the time those items are expected to be recognized for tax purposes.
Results of Operations
The following is a discussion of our results of operations for the three months ended March 31, 2025 and 2024. The tables included in the period comparisons below provide summaries of our results of operations. The period-to-period comparisons of financial results are not necessarily indicative of future results.
Key Operating Metrics
We regularly review a number of key metrics to evaluate our business, measure our performance, identify trends affecting our business, formulate financial projections and make strategic decisions. We also believe these metrics are relevant to investors’ and others’ assessment of our financial condition and results of operations. During the three months ended March 31, 2025 and 2024, we closed 1,706 and 1,564 investment sales, financing and other transactions, respectively, with total sales volume of approximately $9.4 billion and $9.7 billion, respectively. Such key metrics for real estate brokerage and financing activities (excluding other transactions) are as follows:
| | | | | | | | | | | | | | | |
| Three Months Ended March 31, | | |
Real Estate Brokerage | 2025 | | 2024 | | | | |
Average Number of Investment Sales Professionals | 1,578 | | | 1,638 | | | | | |
Average Number of Transactions per Investment Sales Professional | 0.74 | | | 0.67 | | | | | |
Average Commission per Transaction | $ | 105,210 | | | $ | 99,343 | | | | | |
Average Commission Rate | 1.86 | % | | 1.93 | % | | | | |
Average Transaction Size (in thousands) | $ | 5,668 | | | $ | 5,137 | | | | | |
Total Number of Transactions | 1,175 | | | 1,102 | | | | | |
Total Sales Volume (in millions) | $ | 6,659 | | | $ | 5,661 | | | | | |
| | | | | | | | | | | | | | | |
| Three Months Ended March 31, | | |
Financing (1) | 2025 | | 2024 | | | | |
Average Number of Financing Professionals | 102 | | | 99 | | | | | |
Average Number of Transactions per Financing Professional | 3.30 | | | 2.36 | | | | | |
Average Fee per Transaction | $ | 42,702 | | | $ | 47,178 | | | | | |
Average Fee Rate | 0.75 | % | | 0.67 | % | | | | |
Average Transaction Size (in thousands) | $ | 5,721 | | | $ | 7,094 | | | | | |
Total Number of Transactions | 337 | | | 234 | | | | | |
Total Financing Volume (in millions) | $ | 1,928 | | | $ | 1,660 | | | | | |
(1)Operating metrics exclude certain financing fees not directly associated to transactions.
Comparison of Three Months Ended March 31, 2025 and 2024
Below are key operating results for the three months ended March 31, 2025 compared to the three months ended March 31, 2024 (dollars in thousands):
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Three Months Ended March 31, 2025 | | Percentage of Revenue | | Three Months Ended March 31, 2024 | | Percentage of Revenue | | Change |
| | | | Dollar | | Percentage |
Revenue: | | | | | | | | | | | |
Real estate brokerage commissions | $ | 123,622 | | | 85.2 | % | | $ | 109,475 | | | 84.8 | % | | $ | 14,147 | | | 12.9 | % |
Financing fees | 18,130 | | | 12.5 | | | 14,427 | | | 11.2 | | | 3,703 | | | 25.7 | % |
Other revenue | 3,286 | | | 2.3 | | | 5,202 | | | 4.0 | | | (1,916) | | | (36.8) | % |
Total revenue | 145,038 | | | 100 | | | 129,104 | | | 100 | | | 15,934 | | | 12.3 | % |
Operating expenses: | | | | | | | | | | | |
Cost of services | 88,348 | | | 60.9 | | | 76,868 | | | 59.5 | | | 11,480 | | | 14.9 | % |
Selling, general and administrative | 71,552 | | | 49.3 | | | 68,916 | | | 53.4 | | | 2,636 | | | 3.8 | % |
Depreciation and amortization | 2,849 | | | 2.0 | | | 3,422 | | | 2.7 | | | (573) | | | (16.7) | % |
Total operating expenses | 162,749 | | | 112.2 | | | 149,206 | | | 115.6 | | | 13,543 | | | 9.1 | % |
Operating loss | (17,711) | | | (12.2) | | | (20,102) | | | (15.6) | | | 2,391 | | | (11.9) | % |
Other income, net | 3,979 | | | 2.7 | | | 5,568 | | | 4.3 | | | (1,589) | | | (28.5) | % |
Interest expense | (187) | | | (0.1) | | | (199) | | | (0.1) | | | 12 | | | (6.0) | % |
Loss before benefit for income taxes | (13,919) | | | (9.6) | | | (14,733) | | | (11.4) | | | 814 | | | (5.5) | % |
Benefit for income taxes | (9,497) | | | (6.5) | | | (4,746) | | | (3.7) | | | (4,751) | | | 100.1 | % |
Net loss | $ | (4,422) | | | (3.1) | % | | $ | (9,987) | | | (7.7) | % | | $ | 5,565 | | | (55.7) | % |
Adjusted EBITDA(1) | $ | (8,742) | | | (6.0) | % | | $ | (10,082) | | | (7.8) | % | | $ | 1,340 | | | 13.3 | % |
(1)Adjusted EBITDA is not a measurement of our financial performance under U.S. generally accepted accounting principles (“U.S. GAAP”) and should not be considered as an alternative to net loss, operating income or any other measures derived in accordance with U.S. GAAP. For a definition of Adjusted EBITDA and a reconciliation of Adjusted EBITDA to net loss, which is the most directly comparable U.S. GAAP financial measure, see “Non-GAAP Financial Measure” below.
Revenue
Total revenue was $145.0 million for the three months ended March 31, 2025 compared to $129.1 million for the same period in 2024, an increase of $15.9 million, or 12.3%. Total revenue increased as a result of increases in real estate brokerage commissions and financing fees, partially offset by a reduction in other revenue, as described below. See “Factors Affecting Our Business” for additional market information.
Real estate brokerage commissions. Revenue from real estate brokerage commissions increased to $123.6 million for the three months ended March 31, 2025 from $109.5 million for the same period in 2024, an increase of $14.1 million, or 12.9%. The increase was the result of total sales volume increasing by 17.6%, partially offset by a reduction of seven basis points in the average commission rate earned during the three months ended March 31, 2025 compared to the same period in 2024, caused by the shift in the proportion of transactions to the Middle Market and Larger Transaction Market from the Private Client Market, as Middle Market and Larger Transaction Markets typically earn lower commission rates. Private Client Market revenue increased by 6.2%, and the combined Middle Market and Larger Transaction Market revenue increased by 29.6%.
Financing fees. Revenue from financing fees increased to $18.1 million for the three months ended March 31, 2025 from $14.4 million for the same period in 2024, an increase of $3.7 million, or 25.7%, resulting primarily from a 16.1% increase in total financing volume and an eight basis point increase in the average fee rate during the three months ended March 31, 2025 compared to the same period in 2024.
Other revenue. Other revenue decreased to $3.3 million for the three months ended March 31, 2025 from $5.2 million for the same period in 2024, a decrease of $1.9 million, or 36.8%, resulting primarily from a decrease in leasing fees.
Total Operating Expenses
Total operating expenses were $162.7 million for the three months ended March 31, 2025 compared to $149.2 million for the same period in 2024, an increase of $13.5 million, or 9.1%. The change was primarily due to an increase of $11.5 million in cost of services as described below.
Cost of services. Cost of services are variable commissions paid to our investment sales professionals and compensation-related costs in connection with our financing activities. Cost of services increased to $88.3 million for the three months ended March 31, 2025 from $76.9 million for the same period in 2024. Cost of services as a percentage of total revenue increased by 140 basis points to 60.9% compared to the same period in 2024 primarily due to our senior investment sales and financing professionals earning a higher amount of additional commissions.
Selling, general, and administrative expense. Selling, general and administrative expense for the three months ended March 31, 2025 increased to $71.6 million, from $68.9 million for the same period in 2024, an increase of $2.6 million or 3.8%. The increase was primarily due to (i) an increase in compensation related costs and (ii) increased investment in business development, marketing and other support related to the long-term talent acquisition and retention of our investment sales and financing professionals.
Depreciation and amortization expense. Depreciation and amortization expense decreased to $2.8 million for the three months ended March 31, 2025 from $3.4 million compared to the same period in 2024, a decrease of $0.6 million, or 16.7%. The decrease primarily relates to accelerated amortization and impairment of certain intangible assets recorded in the second half of 2024 resulting from changes in estimates.
Other Income, Net
Other income, net decreased to $4.0 million for the three months ended March 31, 2025 from $5.6 million for the same period in 2024. The decrease of $1.6 million was primarily driven by a decrease in interest income due to a decreased average yield on our investments and a decrease in the investment gains and loss related to the assets held in the rabbi trust during the period compared to the same period in prior year.
Interest Expense
Interest expense decreased by an immaterial amount for the three months ended March 31, 2025 compared to the same period in 2024, and primarily relates to interest expense on the Company’s SARs liability.
Benefit for Income Taxes
The benefit for income taxes was $9.5 million for the three months ended March 31, 2025, compared to $4.7 million for the same period in 2024. The effective income tax rate for the three months ended March 31, 2025, was 68.2% compared to 32.2% for the same period in 2024. The net increase in the effective tax rate is primarily due to the relationship of permanent items, the change in the valuation allowance and the change in the state income tax benefit to pre-tax loss as presented in Note 10 – “Income Taxes” in the Notes to the Condensed Consolidated Financial Statements in Item 1, Part I of this Quarterly Report on Form 10-Q.
Non-GAAP Financial Measure
In this Quarterly Report on Form 10-Q, we include a non-GAAP financial measure, Adjusted EBITDA. We define Adjusted EBITDA as net loss before (i) interest income and other, including net realized gains (losses) on marketable debt securities, available-for-sale and cash, cash equivalents, and restricted cash, (ii) interest expense, (iii) benefit for income taxes, (iv) depreciation and amortization, and (v) stock-based compensation. We use Adjusted EBITDA in our business operations to evaluate the performance of our business, develop budgets and measure our performance against those budgets, among other things. We also believe that analysts and investors use Adjusted EBITDA as a supplemental measure to evaluate our overall operating performance. However, Adjusted EBITDA has material limitations as a supplemental metric and should not be considered in isolation, or as a substitute for analysis of our results as reported under U.S. GAAP. We find Adjusted EBITDA to be a useful management metric to assist in evaluating performance, because Adjusted
EBITDA eliminates items related to capital structure, taxes and non-cash items. In light of the foregoing limitations, we do not rely solely on Adjusted EBITDA as a performance measure and also consider our U.S. GAAP results. Adjusted EBITDA is not a measurement of our financial performance under U.S. GAAP and should not be considered as an alternative to net loss, operating loss or any other measures calculated in accordance with U.S. GAAP. Because Adjusted EBITDA is not calculated in the same manner by all companies, it may not be comparable to other similarly titled measures used by other companies. A reconciliation of the most directly comparable U.S. GAAP financial measure, net loss, to Adjusted EBITDA is as follows (in thousands):
| | | | | | | | | | | | | | | |
| Three Months Ended March 31, | | |
| 2025 | | 2024 | | | | |
Net loss | $ | (4,422) | | | $ | (9,987) | | | | | |
Adjustments: | | | | | | | |
Interest income and other(1) | (4,038) | | | (4,765) | | | | | |
Interest expense | 187 | | | 199 | | | | | |
Benefit for income taxes | (9,497) | | | (4,746) | | | | | |
Depreciation and amortization | 2,849 | | | 3,422 | | | | | |
Stock-based compensation | 6,179 | | | 5,795 | | | | | |
Adjusted EBITDA | $ | (8,742) | | | $ | (10,082) | | | | | |
(1)Other includes net realized gains (losses) on marketable debt securities, available-for-sale.
Liquidity and Capital Resources
Our primary sources of liquidity are cash, cash equivalents, and restricted cash, cash flows from operations, marketable debt securities, available-for-sale and, if necessary, borrowings under our Credit Agreement (as defined herein). In order to enhance yield to us, we have invested a portion of our cash in money market funds and fixed and variable income debt securities, in accordance with our investment policy approved by the Board of Directors. Certain of our investments in money market funds may not maintain a stable net asset value and may impose a discretionary liquidity fee. To date, the Company has not experienced any restrictions on its ability to redeem funds from money market funds. Although we have historically funded our operations through operating cash flows, there can be no assurance that we can continue to meet our cash requirements entirely through our operations, cash, net of restricted cash, cash equivalents, and proceeds from the sale of marketable debt securities, available-for-sale or availability under our Credit Agreement.
Cash Flows
Our total cash, cash equivalents, and restricted cash balance decreased by $3.7 million to $149.7 million at March 31, 2025, compared to $153.4 million at December 31, 2024. The following table sets forth our summary cash flows for the three months ended March 31, 2025 and 2024 (in thousands):
| | | | | | | | | | | |
| Three Months Ended March 31, |
| 2025 | | 2024 |
Net cash flows used in operating activities | $ | (52,841) | | | $ | (51,021) | |
Net cash flows provided by (used in) investing activities | 57,168 | | | (21,601) | |
Net cash flows used in financing activities | (8,072) | | | (7,500) | |
Effect of currency exchange rate changes on cash, cash equivalents, and restricted cash | 4 | | | (75) | |
Net decrease in cash, cash equivalents, and restricted cash | (3,741) | | | (80,197) | |
Cash, cash equivalents, and restricted cash at beginning of period | 153,445 | | | 170,753 | |
Cash, cash equivalents, and restricted cash at end of period | $ | 149,704 | | | $ | 90,556 | |
Operating Activities
Cash flows used in operating activities were $52.8 million for the three months ended March 31, 2025 compared to $51.0 million for the same period in 2024. The $1.8 million increase in cash flows used in operating activities for the three
months ended March 31, 2025 compared to the same period in 2024 relates to a number of factors that are largely offsetting. These factors include a reduction in net loss, more than offset by increased payments for bonuses and deferred compensation and commissions in the current year compared to the same period in prior year and the effect of the timing of certain cash receipts and payments.
Investing Activities
Cash flows provided by investing activities were $57.2 million for the three months ended March 31, 2025 compared to cash flows used in investing activities of $21.6 million for the same period in 2024. The $78.8 million increase in cash flows provided by investing activities for the three months ended March 31, 2025 compared to the same period in 2024 was primarily due to a net increase of $77.6 million in proceeds from sales and maturities of securities, net of purchases of securities in 2025 compared to the same period in 2024.
Financing Activities
Cash flows used in financing activities were $8.1 million for the three months ended March 31, 2025, which is comparable to $7.5 million for the same period in 2024.
Liquidity
We believe that our existing balances of cash, cash equivalents, cash flows expected to be generated from our operations, and proceeds from the sale of marketable debt securities, available-for-sale will be sufficient to satisfy our operating requirements for at least the next 12 months and the foreseeable future. If we need to raise additional capital through public or private debt or equity financings, strategic relationships or other arrangements, this capital might not be available to us in a timely manner, on acceptable terms, or at all. Our failure to raise sufficient capital when needed could prevent us from funding acquisitions or otherwise financing our growth or operations. As of March 31, 2025, cash, excluding restricted cash, cash equivalents, and marketable debt securities, available-for-sale, aggregated $319.5 million.
Credit Agreement
Our credit agreement with Wells Fargo Bank, National Association (as amended, the “Credit Agreement”) provides for a $10 million principal amount senior secured revolving credit facility that is guaranteed by all of our domestic subsidiaries and matures on June 1, 2025. The Company maintains a $10 million restricted cash balance in support of the Credit Agreement. The Company is monitoring covenant compliance on a regular basis to ensure continued compliance with the Credit Agreement. Our ability to borrow under our Credit Agreement is limited by our ability to comply with its covenants or obtain necessary waivers. See Note 12 – “Commitments and Contingencies” of our Notes to Condensed Consolidated Financial Statements in Item 1, Part I of this Quarterly Report on Form 10-Q for additional information on the Credit Agreement.
Off Balance Sheet Arrangements
The Company, in connection with the Strategic Alliance with M&T Realty Capital Corporation (“MTRCC”), has agreed to provide loan opportunities that may be funded through MTRCC’s agreement with Fannie Mae, which requires MTRCC to guarantee a portion of each funded loan. On a loan-by-loan basis, the Company, at its option, can assume a portion of MTRCC’s guarantee obligation to Fannie Mae of loan opportunities presented to and closed by MTRCC. As of March 31, 2025, the Company has agreed to a maximum aggregate guarantee obligation of $326.3 million relating to loans with an unpaid balance of $2,011.9 million. The maximum guarantee obligation is not representative of the actual loss we would incur. The Company would be liable for this amount only if all of the loans for which it is providing a guarantee to MTRCC were to default and all of the collateral underlying these loans was determined to be without value at the time of settlement, and the Company has recorded an allowance for losses of $(159,000) as of March 31, 2025 related to these guarantee obligations. The Company is required to provide cash collateral to MTRCC for this obligation, and this is reflected as $0.7 million of restricted cash as of March 31, 2025, which is included in cash, cash equivalents, and restricted cash on the condensed consolidated balance sheet.
Material Cash Requirements
There have been no material changes in our commitments under contractual obligations, as disclosed in our Annual Report on Form 10-K for the year ended December 31, 2024 through the date the condensed consolidated financial
statements were issued, other than for the payment on April 4, 2025 of a semi-annual regular dividend of $0.25 per share on outstanding common stock declared by our Board of Directors on February 6, 2025, aggregating $10.2 million.
Inflation
Our commissions and other variable costs related to revenue are primarily affected by real estate market supply and demand, which may be affected by uncertain or changing economic and market conditions, including inflation/deflation arising in connection with and in response to various macroeconomic factors and impact of increased interest rates on the broader economy.
The annual CPI inflation rate in the U.S. peaked at 9.1% in June 2022, the highest annual inflation rate since November 1981. CPI inflation has since fallen to 2.4% as of March 2025. In 2022 through 2023, the Federal Reserve increased the federal funds rate to the 5.25%-5.5% range in an effort to combat inflation, which had an adverse impact on commercial real estate transactions. In the latter part of 2024, the Federal Reserve lowered the overnight rate by 100 basis points to the 4.25%-4.5% range, which was a positive trend for investors, but the 10-year treasury rate has remained range-bound in the low- to mid-4% range keeping the cost of debt capital elevated.
Looking forward, inflation could rise as the impact of tariffs flow-through to consumers, and the Federal Reserve has communicated a restrained interest rate outlook pending additional clarity on federal fiscal, trade, tax, regulatory and domestic policies. Several of the policies such as tariffs and more stringent immigration controls have the potential to be inflationary in nature, so future inflation risk may depend on when and how assertively the proposed policies are ultimately implemented.
Critical Accounting Estimates
We prepare our financial statements in accordance with U.S. GAAP. In applying many of these accounting principles, we make assumptions, estimates and/or judgments that affect the reported amounts of assets, liabilities, revenues and expenses in our condensed consolidated financial statements. We base our estimates and judgments on historical experience and other assumptions that we believe are reasonable under the circumstances. These assumptions, estimates and/or judgments, however, are often subjective and our actual results may change based on changing circumstances or changes in our analyses. If actual amounts are ultimately different from our estimates, the revisions are included in our results of operations for the period in which the actual amounts become known. There were no significant changes in our critical accounting policies, as disclosed in our Annual Report on Form 10-K for the year ended December 31, 2024 filed with the SEC on February 27, 2025.
Item 3. Quantitative and Qualitative Disclosures About Market Risk
We maintain a portfolio of investments in a variety of fixed and variable debt rate securities, including U.S. Treasuries, U.S. government sponsored entities, corporate debt, asset-backed securities and others. As of March 31, 2025, the fair value of investments in marketable debt securities, available-for-sale was $180.5 million. The primary objective of our investment activity is to maintain the safety of principal and to provide for future liquidity requirements while maximizing yields without significantly increasing risk. While some investments may be securities of companies in foreign countries, all investments are denominated and payable in U.S. dollars. We do not enter into investments for trading or speculative purposes. While our intent is not to sell these investment securities prior to their stated maturities, we may choose to sell any of the securities for strategic reasons including, but not limited to, anticipated capital requirements, anticipation of credit deterioration, duration management, yield management and because a security no longer meets the criteria of our investment policy. We do not use derivatives or similar instruments to manage our interest rate risk. We seek to invest in high quality investments. The weighted average credit rating of our portfolio investments (exclusive of cash, cash equivalents, and restricted cash) was A+ as of March 31, 2025. Maturities are maintained consistent with our short-, medium- and long-term liquidity objectives.
Currently, our portfolio of investments predominantly consists of fixed interest rate debt securities; however, a portion of our investment portfolio may consist of variable interest rate debt securities. Our investments in fixed interest rate debt securities are subject to various market risks. Changes in prevailing interest rates may adversely or positively impact their fair market value should interest rates generally rise or fall. Accordingly, we also may have interest rate risk with variable interest rate debt securities as the income produced may decrease if interest rates fall. Contraction in market liquidity may adversely affect the value of portions of our portfolio and affect our ability to sell securities in the time frames required and at acceptable prices. Uncertainty in future market conditions may raise market participant’s expectations of returns, thus impacting the value of securities in our portfolio as well. The following table sets forth the
impact on the fair value of our investments as of March 31, 2025 from changes in interest rates based on the weighted average duration of the debt securities in our portfolio (in thousands):
| | | | | | | | |
Change in Interest Rates | | Approximate Change in Fair Value of Investments Increase (Decrease) |
2% Decrease ….................. | | $ | 3,657 | |
1% Decrease ….................. | | $ | 1,829 | |
1% Increase ….................. | | $ | (1,830) | |
2% Increase ….................. | | $ | (3,660) | |
Due to the nature of our business and the manner in which we conduct our operations, we believe we do not face any material interest rate risk with respect to other assets and liabilities, equity price risk or other market risks. The functional currency of our Canadian operations is the Canadian dollar. We are exposed to foreign currency exchange rate risk for the settlement of transactions of the Canadian operations as well as unrealized translation adjustments. Historically foreign exchange rate risk has not been material.
Item 4. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Exchange Act Rules 13a-15(f), including maintenance of (i) records that in reasonable detail accurately and fairly reflect the transactions and dispositions of our assets, and (ii) policies and procedures that provide reasonable assurance that (a) transactions are recorded as necessary to permit preparation of financial statements in accordance with accounting principles generally accepted in the United States of America, (b) our receipts and expenditures are being made only in accordance with authorizations of management and our Board of Directors, and (c) we will prevent or timely detect unauthorized acquisition, use, or disposition of our assets that could have a material effect on the financial statements.
Our management, with the supervision and participation of our chief executive officer (“CEO”) and chief financial officer (“CFO”), has evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a- 15(e) and 15d- 15(e) under the Exchange Act), as of the end of the period covered by this Quarterly Report on Form 10-Q, based on the criteria established under the Internal Control Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission in 2013. Based on such evaluation, our management has concluded that as of March 31, 2025, our disclosure controls and procedures are designed at a reasonable assurance level and are effective to provide reasonable assurance that information we are required to disclose in reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the rules and forms of the SEC, and that such information is accumulated and communicated to our management, including our CEO and CFO, as appropriate, to allow timely decisions regarding required disclosure.
Changes in Internal Control over Financial Reporting
There have not been any changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the quarter ended March 31, 2025 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
PART II. OTHER INFORMATION
Item 1. Legal Proceedings
We are involved in claims and legal actions arising in the ordinary course of our business, some of which involve claims for damages that are substantial in amount. Most of these litigation matters are covered by our insurance policies, which contain deductibles, exclusions, claim limits and aggregate policy limits. Such litigation and other proceedings may include, but are not limited to, actions relating to commercial relationships, standard brokerage disputes like the alleged failure to disclose physical or environmental defects or property expenses or contracts, the alleged inadequate disclosure of matters relating to the transaction like the relationships among the parties to the transaction, potential claims or losses pertaining to the asset, vicarious liability based upon conduct of individuals or entities outside of our control, general fraud claims, conflicts of interest claims, employment law claims, including claims challenging the classification of our sales professionals as independent contractors, claims alleging violations of state consumer fraud statutes and intellectual property. While the ultimate liability for these legal proceedings cannot be determined, we review the need for an accrual for loss contingencies quarterly and record an accrual for litigation related losses where the likelihood of loss is both probable and estimable. We do not believe, based on information currently available to us, that the final outcome of these proceedings will have a material adverse effect on our consolidated financial position, results of operations or cash flows.
Item 1A. Risk Factors
There have been no material changes from the risk factors described in our Annual Report on Form 10-K for the year ended December 31, 2024.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
Purchases of Equity Securities by the Issuer
Share repurchase activity during the three months ended March 31, 2025 was as follows:
| | | | | | | | | | | | | | | | | | | | | | | | | | |
Periods | | Total Number of Shares Purchased(1) | | Average Price Paid Per Share | | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs | | Approximate Dollar Value of Shares That May Yet Be Purchased Under the Plans or Programs(2) |
January 1, 2025 - January 31, 2025 | | 12,538 | | | $ | 33.89 | | | 12,538 | | | $ | 70,526,870 | |
February 1, 2025 - February 28, 2025 | | — | | | $ | — | | | — | | | $ | 70,526,870 | |
March 1, 2025 - March 31, 2025 | | — | | | $ | — | | | — | | | $ | 70,526,870 | |
Total | | 12,538 | | | | | 12,538 | | | $ | 70,526,870 | |
(1)Excludes shares withheld for employee taxes upon vesting of stock-based awards. Stock repurchases under our program may be made through open market and privately negotiated transactions at times and in such amounts as management deems appropriate. The timing and actual number of shares repurchased will depend on a variety of factors including price, corporate and regulatory requirements, capital availability, and other market conditions. The stock repurchase program does not have an expiration date and may be limited or terminated at any time without prior notice.
(2)On May 2, 2023, our Board of Directors announced its approval of an additional $70 million to repurchase common stock under its common stock repurchase program, resulting in approximately $70.5 million available to repurchase shares under its common stock repurchase program as of March 31, 2025.
Item 3. Defaults Upon Senior Securities
None.
Item 4. Mine Safety Disclosures
Not Applicable.
Item 5. Other Information
Rule 10b5-1 Trading Plans
Insider Adoption or Termination of Trading Arrangements
During the fiscal quarter ended March 31, 2025, none of our directors or officers informed us of the adoption or termination of a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as those terms are defined in Regulation S-K, Item 408, except as described in the table below:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Name & Title | | Date Adopted | | Character of Trading Arrangement(1) | | Aggregate Number of Shares of Common Stock to be Purchased or Sold Pursuant to Trading Arrangement | | Duration(2) | | Other Material Terms | | Date Terminated |
Steven F. DeGennaro Executive Vice President and Chief Financial Officer | | February 19, 2025 | | Rule 10b5-1 Trading Arrangement | | Up 10,000 shares to be sold | | Earlier of 2/10/2026 or when all shares are sold under the plan. | | N/A | | N/A |
(1)Except as indicated by footnote, each trading arrangement marked as a “Rule 10b5-1 Trading Arrangement” is intended to satisfy the affirmative defense of Rule 10b5-1(c), as amended (the “Rule”).
(2)Except as indicated by footnote, each trading arrangement permitted or permits transactions through and including the earlier to occur of (a) the completion of all purchases or sales or (b) the date listed in the table. Each trading arrangement marked as a “Rule 10b5-1 Trading Arrangement” only permitted or only permits transactions upon expiration of the applicable mandatory cooling-off period under the Rule. Except as indicated by footnote, each arrangement also provided or provides for automatic expiration in the event of death, liquidation, dissolution, bankruptcy, insolvency, termination by the employee or their agent, the broker’s determination or exercise of its termination right as set forth in the arrangement.
Item 6. Exhibits
| | | | | | | | |
Exhibit No. | | Description |
| | |
| | |
| | |
10.1 | | |
| | |
31.1* | | |
| | |
31.2* | | |
| | |
32.1** | | |
| | |
101* | | The following financial statements from the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2025, formatted in Inline XBRL: (i) Condensed Consolidated Balance Sheets, (ii) Condensed Consolidated Statements of Operations, (iii) Condensed Consolidated Statements of Comprehensive Loss, (iv) Condensed Consolidated Statements of Stockholders’ Equity, (v) Condensed Consolidated Statements of Cash Flows, and (vi) Notes to Condensed Consolidated Financial Statements, tagged as blocks of text and including detailed tags. |
| | |
104* | | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) |
____________
* Filed herewith.
** Furnished, not filed.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| | | | | | | | | | | | | | |
| | | | Marcus & Millichap, Inc. |
| | | | |
Date: | May 7, 2025 | | By: | /s/ Hessam Nadji |
| | | | Hessam Nadji President and Chief Executive Officer (Principal Executive Officer) |
| | | | |
Date: | May 7, 2025 | | By: | /s/ Steven F. DeGennaro |
| | | | Steven F. DeGennaro Chief Financial Officer (Principal Financial Officer) |